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Summary 
The human gastrointestinal tract is colonized by a dense and complex community of bacteria. 
The intestinal microbiota has a large impact on the health of the host and the intestinal bacteria 
are roughly classified as either potential deleterious or potential beneficial bacteria. Several 
factors can affect the composition of the microbiota - among them prebiotics. Prebiotics are food 
ingredients that are non-digestible for the human body and therefore reach the large intestine in 
an intact form. In the large intestine the prebiotics selectively stimulate the growth of the 
beneficial rather than the harmful bacteria of the microbiota. 
Gastro-intestinal infections currently cause several hundred thousand reported cases of disease in 
the EU each year. Infections with the forborne pathogen Listeria monocytogenes are relatively 
rare, but it is one of the most severe infections in the industrialised countries with a mortality of 
about 30%. 
The gut has a very important function in defending the host against infections with ingested 
pathogenic bacteria and there is increasing evidence that prebiotics can help strengthen this 
defense. This is done through stimulation of beneficial intestinal bacteria that release 
bacteriocins toxic for the pathogens, lower the pH to a level that is unfavourable for pathogenic 
bacteria and compete with the pathogen for nutrients and mucosal adhesion sites in the intestine. 
However, besides the microbiota dependent mechanisms increasing evidence suggest that 
prebiotics exert their protective function against pathogens through microbiota independent 
mechanisms. This is thought to be done by blocking the pathogenic adhesion to intestinal cells, 
affecting the expression of virulence genes from the pathogen and by stimulating the immune 
system. 
In vivo evidence of the prebiotics effect against pathogenic enteric infections is scarce and I 
therefore investigated the effect of five non-digestible carbohydrates (putative prebiotics) on the 
resistance of guinea pigs to infection with three different strains of L. monocytogenes. Animals 
were fed a diet supplemented with either 10% xylooligosaccharides (XOS), 
galactooligosaccharides (GOS), inulin, apple pectin or polydextrose for three weeks before oral 
challenge with L. monocytogenes. XOS and GOS significantly improved resistance of guinea 
pigs to L. monocytogenes, while inulin and apple pectin decreased the resistance. No significant 
effect on resistance to L. monocytogenes was seen after feeding with polydextrose. To further 
explore the mechanisms behind these in vivo observations, microbiota independent effects of 
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four of the carbohydrates (XOS, GOS, inulin and polydextrose) on the adhesive and infective 
potential of L. monocytogenes was investigated. Mixing L. monocytogenes with XOS just prior 
to infection decreased the adherence of two of the three strains of L. monocytogenes to the 
intestinal cell line Caco-2. Additionally, 2 hours incubation with XOS and subsequently washing 
of the bacteria decreased the adherence of all three strains of L. monocytogenes to Caco-2 cells. 
No effect on adhesion was seen for either GOS, inulin or polydextrose.  
Adherence to the intestinal epithelium is considered a very important step in the infection cycle 
for most of the pathogenic bacteria. Without adherence the pathogenic bacteria are rapidly 
eliminated from the intestine. The ability of the four carbohydrates to affect the expression of L. 
monocytogenes genes known to be involved in adherence to intestinal cells (inlA, lap, ami, iap, 
aut, fdpA, actA) was therefore investigated. It was found that expression of the adhesion genes 
was affected in a strain dependent manner by the presence of prebiotics in the growth media. 
In conclusion, these results show that different non-digestible carbohydrates can have entirely 
different effects on the in vivo infectivity of L. monocytogenes and that microbiota independent 
mechanisms might be involved. All the tested carbohydrates affected expression of adherence 
genes but only XOS affected the in vitro adhesion of L. monocytogenes to intestinal cell. This 
may suggest that different mechanisms are responsible for the observed in vivo effect of the 
different non-digestible carbohydrates. Mostly microbiota independent mechanisms were 
investigated in this project, but it is very likely that microbiota dependent mechanisms also are 
involved.  
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Dansk sammendrag 
Den menneskelige mave-tarmkanal er koloniseret af et tæt og kompleks samfund af bakterier. 
Tarmens mikrobiota har en stor indvirkning på sundheden hos værten og tarmbakterier kan groft 
klassificeret som enten potentielt skadelige eller potentielt gavnlige. Flere faktorer kan påvirke 
sammensætningen af mikrobiotaen – herunder prebiotika. Prebiotika er fødevare komponenter, 
der ikke kan nedbrydes i den menneskelige gastrointestinale kanal og derfor når tyktarmen i 
intakt form. I tyktarmen stimulerer prebiotika hovedsageligt de gavnlige frem for skadelige 
bakterier i mikrobiotaen. 
Hvert år bliver flere hundrede tusinde mennesker, alene i EU, syge af mavetarm infektioner. 
Infektioner med den fødevarebårne patogene bakterie Listeria monocytogenes er forholdsvis 
sjældne, men med en dødelighed på omkring 30% er det en af de mest alvorlige infektioner i de 
industrialiserede lande. 
Tarmens microbiota har en meget vigtig funktion i at beskytte værten mod infektioner med 
patogene bakterier fra maden, og flere og flere beviser tyder på at prebiotika kan medvirke til at 
styrke denne beskyttelse. Dette sker ved stimulering af de gavnlige tarmbakterier der derved 
frigiver bakteriociner der er giftige for de patogene bakterier, sænker pH til et niveau der er 
ugunstig for de patogene bakterier og konkurrence med de patogene bakterier om næringsstoffer 
og adhæsions receptorer i tarmen. Ud over de mikrobiota afhængige mekanismer er der stadig 
flere tegn på, at prebiotika kan udøve sin beskyttende funktion mod patogene bakterier gennem 
mikrobiota uafhængige mekanismer. Dette menes at ske ved blokering af de patogene bakteriers 
adhæsions receptorer, påvirkning af ekspression af virulens gener og ved at stimulere 
immunforsvaret. 
Indtil nu er der kun udført få in vivo infektionsforsøg med prebiotika, og derfor har jeg undersøgt 
hvilken effekt fem ikke-fordøjelige kulhydrater (formodede prebiotika) har på marsvins 
modstandsdygtighed overfor tre L. monocytogenes stammer. Dyrene blev i tre uger fodret med 
en kost suppleret med enten 10% xylooligosaccharider (XOS), galactooligosaccharider (GOS), 
inulin, æble pektin eller polydextrose, før de blev oralt inficeret med L. monocytogenes. XOS og 
GOS forbedrede marsvinenes modstandsdygtighed overfor L. monocytogenes infektionen, mens 
inulin og æble pektin fik modstandsdygtigheden til at falde. Der var ingen effekt efter fodring 
med polydextrose. For yderligere at udforske de mekanismer der ligger til grund for in vivo 
observationerne, blev fire af kulhydraternes (XOS, GOS, inulin og polydextrose) mikrobiota 
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uafhængige virkninger på infektionspotentialet af L. monocytogenes undersøgt. Ved tilsætning af 
XOS lige inden infektion faldt adhæsionen til tarm cellelinjen Caco-2 af to af de tre L. 
monocytogenes stammer. To timers inkubation med XOS og efterfølgende vask af L. 
monocytogenes bakterierne fik også adhæsionen til Caco-2 cellerne af alle tre stammer til at 
falde. Hverken GOS, inulin eller polydextrose havde effekt på adhæsionen af L. monocytogenes 
in vitro. 
Adhæsion til tarm epitelet betragtes, for de fleste patogene bakterier, som et meget vigtigt trin i 
infektionscyklussen. Uden adhæsion vaskes de patogene bakterier meget hurtigt ud af tarmen. 
Derfor blev de fire kulhydraters påvirkning af ekspressionen af syv gener (inlA, lap, ami, iap, 
aut, fdpA, actA) der menes at være involveret i adhæsion af L. monocytogenes til tarm epitelet 
undersøgt. Dette viste at ekspressionen af adhæsionsgenerne blev påvirket på en stamme 
afhængig måde af tilstedeværelse af kulhydraterne. 
Ud fra disse resultater kan det konkluderes, at forskellige ikke-fordøjelige kulhydrater kan have 
helt forskellige virkninger på in vivo infektiviteten af L. monocytogenes, og at mikrobiota 
uafhængige mekanismer kan være involveret. Alle de testede kulhydrater påvirkede 
ekspressionen af adhæsionsgenerne, mens kun XOS påvirkede adhæsionen af L. monocytogenes 
til epitel cellerne. Dette kan tyde på, at det er forskellige mekanismer, der er ansvarlig for de 
observerede in vivo effekter af de forskellige ikke-fordøjelige kulhydrater. Hovedsageligt 
mikrobiota uafhængig mekanisme er blevet undersøgt i dette projekt, men det er meget 
sandsynligt, at mikrobiota afhængige mekanismer også kan være involveret. 
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Objectives of the study 
Foodborne gastrointestinal infections are a serious problem affecting public health worldwide. 
Gastro-intestinal infections currently cause several hundred thousand reported cases of disease 
alone in the EU each year. From a health and socioeconomic perspective the distress, possible 
medical treatment, hospitalization and loss of working power following a gastrointestinal 
infection presents a serious problem. Listeriosis caused by the foodborne pathogen Listeria 
monocytogenes is a very severe disease with a mortality rate of 20-30% despite fast treatment 
with antibiotics (Vazquez-Boland et al., 2001). Listeria infections are relatively rare, however, a 
reduction in the occurrence is very important given the high mortality rate. For unknown reasons 
Denmark has for a number of years had the highest occurrence of listeriosis in the EU (EFSA 
Annual Report, 2007).  
The aim of this study was to utilize guinea pigs to identify dietary prebiotic carbohydrates 
inhibiting infections with L. monocytogenes and to further explore the mechanisms behind this 
expected preventive effect. The intension was to analyze what impact feeding of prebiotic had on 
the intestinal microbiota of guinea pigs and to compare it to the observed in vivo effects. I 
therefore isolated feacal DNA from guinea pigs before and after feeding with prebiotics and sent 
it to BGI-Shenzhen, China to obtain metagenome information by Solexa sequencing. However, I 
did not receive any data from China so I instead decided to investigate the direct interactions 
between prebiotics, Listeria monocytogenes and the intestinal epithelium. 
 
The first part of this thesis gives a theoretical introduction to Listeria monocytogenes, the 
gastrointestinal tract and prebiotics. The second part contains two manuscripts where my work 
constitutes the core. I have furthermore contributed in the making of two manuscripts: 
“Response of Listeria monocytogenes to oxygen restriction: A microarray-based transcription 
analysis” and “Characterization of serum amyloid A as an acute phase protein in the guinea pig”. 
However, as the focus of these two manuscripts is in the periphery of the scope of my Ph.D. 
work these manuscripts are not included in the thesis.  
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Listeria monocytogenes 
 
Listeria 
The gram-positive bacterial genus Listeria consists of a group of facultative intracellular and 
facultative anaerobic bacteria. Listeria are very widely distributed in nature and can be found in 
many environmental sources including feces from humans and animals, soil, water and in a large 
variety of foods (Vazquez-Boland et al., 2001). Listeria is acquired by eating contaminated food 
products and can cause acute, self limited gastroenteritis in otherwise healthy individuals (Ooi 
and Lorber, 2005) and the more severe invasive disease listeriosis in immunocompromised 
patients. Although Listeria has been isolated from nearly all kinds of food, food most often 
contaminated is raw products consumed without prior cooking or reheating. In the small intestine 
Listeria enters cells of the intestinal epithelium and pass in that way through the intestinal 
barrier. The Listeria bacteria are carried via the blood to the liver which is the main site of 
replication. In severe cases, Listeria infects the central nervous system leading to meningitis or 
infects the placenta of pregnant women leading to infections of the fetus (Sleator et al., 2009). 
The genus Listeria includes six species of which only two species Listeria monocytogenes (L. 
monocytogenes) and L. ivanovii are potentially pathogenic to humans (Vazquez-Boland et al., 
2001). Human infections with L. ivanovii (predominantly infects ruminants) are very rare 
(Cummins et al., 1994;Guillet et al., 2010) and L. monocytogenes account for almost all reported 
cases of human listeriosis (EFSA Annual Report, 2007). Listeriosis is usually a very severe 
disease with a mortality rate of 20-30% despite fast treatment with antibiotics. Human infections 
with Listeria are relatively rare (0.3 cases per population of 100,000 in the EU in 2007) yet 
important to investigate given the severity of symptoms and the high mortality rate. For 
unknown reasons Denmark has for a number of years had the highest notification rate in EU with 
1.1 cases of listeriosis per population of 100,000 (EFSA Annual Report, 2007). 
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Survival in the gastrointestinal tract 
The pathophysiology of L. monocytogenes infection in humans and animals is still poorly 
understood. Most of our knowledge is a result of observations from experimental infections of 
animals and interpretation of epidemiological and histopathological findings (Mead et al., 1999).  
Inside the body L. monocytogenes has to withstand a lot of adverse environments before it 
transiently can colonize the intestine and invade the body. In the stomach, L. monocytogenes has 
to survive the acidic conditions. Treatment of patients or animals with antacids has shown to 
reduce resistance to L. monocytogenes indicating that the acidity of the stomach destroys a 
significant number of L. monocytogenes (Donnelly, 2001). It is known that moderately acidic 
conditions (pH 5-5.5) can start an adaptive response that can enhance survival of L. 
monocytogenes under conditions of otherwise lethal pH (pH 3.5) (Davis et al., 1996;O'Driscoll et 
al., 1996). This stress response might increase survival in the gastrointestinal (GI) tract and later 
within the macrophage phagosome. 
A similar “stress hardening” response is thought to be started when L. monocytogenes is grown 
under anaerobic conditions. Andersen et al (2007) showed that oxygen restriction increased the 
infective potential of L. monocytogenes both in vitro and in vivo in oral infection assays of 
guinea pigs. Unpublished results suggest that this increase in infectivity is due to an increased 
expression of genes known to be important for L. monocytogenes adhesion and invasion of 
epithelial cells (Andersen, personal communication). 
Passage from the stomach to the small intestine involves an osmotic upshift for L. 
monocytogenes. To counterbalance this high turgor pressure L. monocytogenes transports 
osmolytes into the bacterial cell and in that way prevents water loss from the bacteria (Gahan 
and Hill, 2005). 
Once in the small intestine L. monocytogenes also has to tolerate the bactericidal activities of 
bile. Several genes are involved in this response however, one gene, bile salt hydrolase (bsh) is 
of particular importance. bsh is absent from nonpathogenic Listeria species and it has been 
shown that bsh is involved in the persistence of L. monocytogenes in the small intestine of oral 
infected guinea pigs (Dussurget et al., 2002). Rather surprisingly, despite the high concentration 
of bile L. monocytogenes is able to colonize the gall bladder of mice (Hardy et al., 2004). This is 
found to be a result of the neutral pH in the gall bladder making L. monocytogenes more resistant 
to high concentrations of bile (Begley et al., 2005). 
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Adherence to and invasion of the gastrointestinal mucosa 
L. monocytogenes has multiple strategies to invade a wide range of mammalian cells. L. 
monocytogenes can be engulfed by professional phagocytes such as M-cells, however, the main 
way of entrance into hosts normally susceptible to L. monocytogenes is for the bacteria to 
“force” their own entry into otherwise non-phagocytic cells such as intestinal enterocytes and 
hepatocytes (Lecuit et al., 2001;Corr et al., 2006). 
The initial crossing of the intestinal barrier by L. monocytogenes is obviously very crucial in 
initiating the infection and during the years a lot of research has been done in this field. Galliard 
et al (1991) showed that the protein Internalin A (InlA) is responsible for the invasion of L. 
monocytogenes into epithelial cell lines and in 2001 the importance of InlA for adherence and 
invasion of L. monocytogenes was confirmed in vivo (Lecuit et al., 2001). However, because a 
very rapid translocation to internal organs is seen after inoculation of rats and mice with L. 
monocytogenes (Pron et al., 1998;Daniels et al., 2000) it was long speculated that L. 
monocytogenes also used a rapid non-specific transport system to cross the intestinal barrier. 
This was confirmed by Corr et al (2006) which showed that L. monocytogenes, without 
involving the classical virulence factors, can colonize murine Peyers patches in vivo and 
translocate through M cells in vitro. 
Even though, it is generally believed that InlA is the primary protein involved in infection of 
enterocytes by L. monocytogenes, evidence suggest that yet other proteins may be involved in 
this process. How big a role these proteins play in the crossing of the intestinal barrier is far from 
elucidated because experiments are few and mainly done in vitro. For some of these proteins 
namely the autolysins their role might be fine tuning of the surface architecture of L. 
monocytogenes priming the bacteria for adherence and invasion of enterocytes. The role for 
other proteins might be to mediate a first unspecific binding between L. monocytogenes and the 
host cell bringing the two cells so close that a second host/cell specific binding can take place. 
And yet other proteins involved in the adherence may have a completely different way of 
function (Milohanic et al., 2001). I will in the following section describe Internalin A and some 
of the proteins believed to be important for the adherence and invasion of L. monocytogenes into 
enterocytes. 
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Internalin A 
L. monocytogenes primarily enters mammalian cells through the action of two surface proteins 
Internalin A (InlA) and InlB (Gaillard et al., 1991). InlA is attached to the cell surface while InlB 
only is loosely associated to the bacterial surface and also exit as a released soluble form (Khelef 
et al., 2006). The inlA and inlB genes are only found in L. monocytogenes strains and not in the 
non-pathogenic L. innocua strains (Gaillard et al., 1991;Glaser et al., 2001). InlA are believed to 
be the principal protein involved in uptake of Listeria into enterocytes (Lecuit et al., 2001) and it 
is also believed to play a critical role in the crossing of the placenta (Lecuit et al., 2001;Disson et 
al., 2008). InlA binds to the epithelial receptor E-cadherin (Mengaud et al., 1996) which is 
located below the tight junctions between polarized epithelial cells (Pentecost et al., 2006). 
Normally, InlA have no access to E-cadherin but during extrusion of apoptotic cells at the villous 
tips E-cadherin is exposed to the luminal surface. It has been shown that L. monocytogenes takes 
advantage of this process to adhere to E-cadherin (Pentecost et al., 2006). Binding of InlA to E-
cadherin promotes a complex host signaling cascade and reorganization of the cytoskeleton in 
the enterocytes leading to internalization of L. monocytogenes (Bonazzi et al., 2009). Latex 
beads coated with InlA or expression of InlA by the normally non-invasive L. innocua is 
sufficient to promote phagocytosis into epithelial cell lines in vitro (Lecuit et al., 1997;Pron et 
al., 1998). Studies have shown that if a Listeria strain contains a truncated inlA gene the 
efficiency of internalization into cultured cell lines will be low (Jonquieres et al., 1998). In 
continuation of this it has been shown that a significantly higher number of clinical Listeria 
strains involved in bacteremia contains full length InlA compared to Listeria strains isolated 
from food (Jacquet et al., 2004). Also epidemiological studies have shown that L. 
monocytogenes strains with full length InlA are associated with isolates from pregnancy-related 
cases (Jacquet et al., 2004;Disson et al., 2008). This clearly shows the importance of InlA for the 
virulence of L. monocytogenes.  
InlB is required for the systemic spread of L. monocytogenes and is important for the invasion of 
hepatocytes and placenta (Disson et al., 2008). Until recently it was not possible to demonstrate 
a role for InlB in the intestinal phase of infection. However, a very recent study suggests that 
after L. monocytogenes has attached to the intestinal epithelium InlB activates its receptor Met. 
This leads to an acceleration of the internalization of L. monocytogenes by increasing the 
endocytosis of junctional components (Pentecost et al., 2010). 
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Listeria adhesion protein 
Listeria adhesion protein (LAP) is one of the proteins that have been shown to be involved in 
adhesion of L. monocytogenes to intestinal cells (Pandiripally et al., 1999;Jaradat et al., 2003). 
Deletion of lap does not seem to have any effect on the adhesion of L. monocytogenes to non-
intestinal cell lines e.g. from the liver, kidney and bladder (Jaradat et al., 2003). After oral 
administration of mice with either a wild-type (wt) strain or a LAP-deficient strain a significantly 
higher number of wt L. monocytogenes was found in the liver. Intraperitoneal infection of mice 
showed no difference between the two strains suggesting that the LAP-deficient strain was 
unable to cross the intestinal barrier (Jaradat et al., 2003). LAP is identified as an alcohol 
acetaldehyde dehydrogenase, which in other bacteria is involved in adherence to eukaryotic cells 
(Kim et al., 2006). LAP is found mainly in the cytoplasm, with only a few proteins (10-15%) 
located on the cell membrane (Jaradat and Bhunia, 2002). Expression of lap is induced by 
nutrient-limitation (Jaradat and Bhunia, 2002), temperature around 37°C (Santiago et al., 1999) 
and anaerobicity (Burkholder et al., 2009) - all factors found in the GI tract. The heat shock 
protein 60 (Hsp60) has been shown to act as a receptor for LAP (Wampler et al., 2004). Hsp60 is 
a mitochondrial chaperone, however, it has also been found in the membrane in a variety of cell 
types, including intestinal epithelial cells (Soltys and Gupta, 1997).  
 
Fibronectin‐binding protein A 
Human fibronectin is a glycoprotein found in plasma and extracellular fluids and as an insoluble 
form in the extracellular matrix (Gilot et al., 1999). Fibronectin is involved in a number of 
eukaryotic cellular processes but is also known to work as an attachment protein for several 
pathogenic bacteria (Courtney et al., 1994;Fowler et al., 2000). L. monocytogenes binds to 
fibronectin via fibronectin-binding protein A (FdpA) and infectious studies with a fdpA deletion 
strain in transgenic mice have shown a significantly lower number of L. monocytogenes in the 
intestine, lymph nodes and liver compared to infections with a wt strain (Gilot et al., 
2000;Dramsi et al., 2004). In oral infections of mice not having a functional receptor for InlA 
(see paragraph “Animal models used for infection studies with L. monocytogenes”) no difference 
in the number of L. monocytogenes in the intestine and organs are seen between the two strains 
(Dramsi et al., 2004). This indicates that FdpA is dependent on the InlA-E-cadherin interaction 
to perform its function in helping L. monocytogenes cross the intestinal barrier. 
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ActA 
The surface protein ActA is a major virulence factor of L. monocytogenes mediating actin-based 
intra- and intercellular spread (Smith et al., 1995). However, it has suggested that ActA also is 
implicated in epithelial cell invasion (varez-Dominguez et al., 1997). The ability of L. 
monocytogenes to adhere to several eukaryotic cell lines, among them intestinal cell lines, is 
impaired if ActA is deleted, and furthermore, expression of ActA enables L. innocua to invade 
epithelial cells (Suarez et al., 2001). ActA binds to the ubiquitously distributed human heparin 
sulfate proteoglycan and this binding might be involved in ActA function in adhesion of L. 
monocytogenes (varez-Dominguez et al., 1997;Suarez et al., 2001). Further studies need to be 
done to elucidate what role ActA plays in the adhesion process of L. monocytogenes. 
 
Ami 
Bacterial autolysins are endogenous enzymes that digest the cell wall peptidoglycan of their own 
cell walls. These molecules have been implicated in various biological functions, such as 
regulation of cell growth, cell division and protein secretion (Popowska, 2004). 
In 1997 Braun et al. (1997) identified Ami, a protein with autolytic activity exclusively found on 
the surface of L. monocytogenes. A significant loss of adherence to eukaryotic intestinal cell 
lines in vitro is seen if ami is inactivated in an inlA and/or inlB mutant (Milohanic et al., 
2000;Milohanic et al., 2001). However, this loss of adhesion is not seen in a wt strain, suggesting 
that InlA and InlB are able to overcome the defect in Ami mediated adhesion (Milohanic et al., 
2001). In mice, intravenously infected with either an ami deletion strain or a strain where both 
ami, inlA and inlB are deleted fewer L. monocytogenes are seen of the two deletions strains in the 
liver compared to infection with a wt strain. This indicates that Ami might also play a role after 
the translocation of the epithelial tissue (Milohanic et al., 2001). The disruption of ami only 
affects the adhesion of L. monocytogenes and not the ability to grow once L. monocytogenes is 
internalised into the eukaryotic cell (Milohanic et al., 2000). The C-terminal domain of Ami is 
believed to be responsible for the attachment of L. monocytogenes to eukaryotic cells and if ami 
is inactivated in an inlA and/or inlB background the expression of this domain fully restores the 
adhesion (Milohanic et al., 2001).  
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p60 
The protein p60 (gene name iap) is another autolysin also believed to be involved in the 
adherence of L. monocytogenes to intestinal cells (Kuhn and Goebel, 1989). p60 is found both on 
the cell surface and as a secreted protein and is required for proper cell division of L. 
monocytogenes (Kuhn and Goebel, 1989;Ruhland et al., 1993). Free p60 directly binds to 
intestinal epithelial cells with high specificity (Park et al., 2000) correlating with several studies 
showing that in the absence of p60 the invasiveness of L. monocytogenes into intestinal epithelial 
cell is reduced (Pilgrim et al., 2003;Faith et al., 2007). Once inside the epithelial cell the p60 
mutant escapes from the phagosome and grows in the cytosol with the same efficiency as a wt 
stain. However, the deletion mutant fails to produce actin tails, which results in reduced 
intracellular movement and reduced cell-to-cell spread (Pilgrim et al., 2003). After 
intragastrically infection of mice with a L. monocytogenes p60 mutant, significantly fewer L. 
monocytogenes bacteria are found in caecum and in the internal organs (Faith et al., 2007). The 
fact that fewer bacteria are present in the caecum might indicate that p60 is required for maximal 
virulence of L. monocytogenes already in the gastrointestinal tract. 
 
Auto 
Auto is yet another L. monocytogenes autolysin involved in entry of L. monocytogenes to 
intestinal cells (Cabanes et al., 2004). Auto is essential for entrance of L. monocytogenes into 
several cell lines among them intestinal cell lines. Fewer Listeria bacteria were found in the 
intestine and organs after oral infection of guinea pigs. Similarly, fewer Listeria bacteria were 
found in the organs of mice after intravenous infection with an auto deletion strain compared 
with infection with a wt strain (Cabanes et al., 2004). This implies that Auto is involved both in 
the intestinal phase and in later stages of the infectious process. Bublitz et al., (2009) suggests 
that Auto might be involved in coordinating the release of virulence factors at the right stages of 
infection. 
 
Animal models used for infection studies with L. monocytogenes 
Previously, mice have been the most extensively used animal model to study the 
pathophysiology of L. monocytogenes and the immune response to L. monocytogenes. However, 
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observations showing that in murine cell lines, no difference in entry was observed between L. 
monocytogenes and InlA mutant led to the discovery that InlA exhibit species specificity for 
some E-cadherins (Lecuit et al., 1999). Interaction between InlA and E-cadherin is completely 
impaired in mouse and rats whereas it is functional in a lot of other mammalian species e.g. 
guinea pigs, rabbits, humans and gerbils (Lecuit et al., 1999;Disson et al., 2008) (see figure 1). A 
proline in position 16 of E-cadherin was shown to be responsible for this species specificity. 
Substitution of this proline with glutamic acid as seen in the E-cadherin of mouse and rat 
completely abrogate interaction between InlA and E-cadherin (Lecuit et al., 1999).  
Not all of the symptoms of a L. monocytogenes infection in guinea pigs and rabbits are similar to 
those of human listeriosis. Infections in guinea pigs and rabbits do not lead to an efficient 
infection in the central nervous system, which is often seen in humans (Gray and Killinger, 
1966). Inspired by the discovery of the species specificity of InlA and E-cadherin, Khelef et al. 
(2006) found that species specificity was also involved in the binding of InlB to its receptors Met 
(Shen et al., 2000) and gClq-R (Braun et al., 2000). InlB is unable to interact with its receptors in 
guinea pig and rabbit and therefore it cannot promote entry (Khelef et al., 2006) (see figure 1). 
 
 
Figure 1: Species specificity between InlA and E-cadherin and between InlB and Met. Reprinted from 
(Lecuit, 2007). 
 
These species specificities clearly show that all of the above described animal models have their 
drawbacks in mimicking human listeriosis. However, these models can be used as long as you 
carefully keep in mind the limitations of the model and what questions you want to answer. 
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Now, novel animal models have been developed to study listeriosis after oral inoculation. Two 
genetically engineered mouse lines have been developed. The first was a transgenic mouse line 
where human E-cadherin was exclusively expressed in the enterocytes of the small intestinal 
(Lecuit et al., 2001). The disadvantage of this model is that the role of interaction between InlA 
and E-cadherin in other tissue than the small intestine (e.g. the colon, caecum, placenta and the 
blood-brain barriers) cannot be assessed. Recently, a new genetically engineered mouse line has 
been developed that account for this tissue problem. In this knock-in E16P mouse line the 
glutamic acid at position 16 of the endogenous mouse E-cadherin has been replaced with a 
proline resulting in binding between InlA and the mouse E-cadherin (Disson et al., 2008). 
 
Intracellular life cycle of L. monocytogenes 
After entrance into the host cell either by phagocytosis into professional phagocytotic cells or by 
induced phagocytosis into non-phagocytosis cells L. monocytogenes undergoes a characteristic 
replication cycle (figure 2) (Hamon et al., 2006). This cycle starts by interaction between the 
plasma membrane and L. monocytogenes causing the plasma membrane to enwrap the bacteria 
by a so called “zipper” mechanism (figure 2a) (Swanson and Baer, 1995;Mengaud et al., 1996). 
After penetration of the cell membrane the L. monocytogenes bacteria become engulfed within a 
phagocytic vacuole, which shortly after becomes acidified (figure 2b). Already two hours after 
entry about 50% of the L. monocytogenes bacteria are free in the cytoplasm where they 
multiplies (figure 2c). An actin tail is formed at one of the poles of the bacteria leading to 
random movement in the cytoplasm (figure 2d). Some of the L. monocytogenes bacteria reach 
the cell membrane and make a finger-like protrusion that can penetrate neighbouring cells (figure 
2e). Inside the new cell, the bacteria are engulfed in a secondary double-membrane phagosome 
of which the bacteria quickly escapes and a new replication cycle can begin (figure 2f) (Hamon 
et al., 2006).  
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Figure 2: Schematic representation and electron micrographs of the different stages of the intracellular 
life cycle of L. monocytogenes. a: Adhesion to and penetration of the eukaryotic cell. b: Survival within 
the phagocytic vacuole (phagosome). c: Escape from the phagosome and replication in the cytosol. d: 
Actin-based motility. e: Actin polymerization allows L. monocytogenes to move in the cytosol and form a 
finger-like protrusion leading to penetration of neighbouring cells. f: Escape from the double-membraned 
secondary phagosome and beginning of a new replication cycle. Reprinted from (Hamon et al., 2006). 
 
Carbohydrates and gene expression in L. monocytogenes 
The ability of L. monocytogenes to sense differences in the environment and hereafter to conduct 
an appropriate gene response may be crucial for the success as a pathogen. One of the best 
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known examples of this is the temperature-dependent control of Positive regulatory factor A 
(PrfA) which is the master virulence regulator of L. monocytogenes. A posttranscriptional 
thermoregulation ensures that PrfA and with that most of the virulence genes, only are expressed 
at temperatures found inside a host (Leimeister-Wachter et al., 1992;Johansson et al., 2002). 
Another example of the ability of L. monocytogenes to act according to the environment is the 
repression of virulence genes in response to certain fermentable carbohydrates that L. 
monocytogenes may find outside a host (Park and Kroll, 1993;Park, 1994;Milenbachs et al., 
1997;Gilbreth et al., 2004;Larsen et al., 2006). This ability seems in some degree to be strain 
dependent (Park and Kroll, 1993;Milenbachs et al., 1997). The exact mechanism behind this 
carbon mediated repression of virulence genes has not been elucidated yet but the virulence 
genes are only repressed by carbohydrates that can be readily metabolized by L. monocytogenes 
and only when present in amounts able to enhance growth (Premaratne et al., 1991;Milenbachs 
et al., 1997). However, it should be noted that growth enhancement by a carbohydrate is not in 
itself enough to repress the virulence genes (Milenbachs et al., 1997). It cannot be ruled out that 
the carbohydrates in itself function as a signaling molecule although it is more likely that the 
repression of virulence genes are under a more global control, such as catabolite repression 
(Milenbachs et al., 1997;Gilbreth et al., 2004). 
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The gastrointestinal tract 
 
The human gastrointestinal tract 
The major structures of the human gastrointestinal (GI) tract are: the oral cavity, esophagus, 
stomach, small intestine, colon, rectum and anus. The small intestine is composed of the 
duodenum, the jejunum and the ileum while the caecum, ascending colon, transverse colon, 
descending colon and sigmoid rectum make up the colon (Kutchai, 1998) (see Figure 3).  
 
 
 
Figure 3: Schematic representation of the human gastrointestinal system. 
 
The GI tract plus the associated organs, salivary glands, liver, gallbladder and pancreas, make up 
the GI system. The major function of the GI system is to digest ingested food and absorb the 
nutrients into the body. The digestion and absorption of nutrients depends greatly upon 
movements of the GI tract which soften, and mix the GI content with secretions from the 
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associated glands and move it along the tract. The secretion of substances into the GI content is 
very important for degradation of food particles into molecules that can be absorbed by the body. 
Interplay between hormones, paracrine molecules and neurons regulates the function of the GI 
tract (Kutchai, 1998). 
 
Digestion of carbohydrates 
The major sources of carbohydrates in the human diet are polysaccharides (e.g. starches and 
nonstarch polysaccharides), disaccharides (e.g. sucrose and lactose) and monosaccharides (e.g. 
glucose and fructose) (Kutchai, 1998;Roberfroid, 2005c). Most carbohydrates have to be 
digested in the GI tract before absorption since epithelial cells only absorb carbohydrates in the 
form of monosaccharides. 
Most of the digestion and absorption of carbohydrates takes place in the small intestine with 
relatively low activity in the duodenum, high activity in the jejunum and then again low activity 
in the ileum (Roberfroid, 2005b). However, the first digestion of starch already begins in the 
mouth where α-amylase from the saliva catalyzes the hydrolysis of the internal α-1.4 linked 
polymer of glucose into oligo- and di-saccharides. The digestion by α-amylase continues until 
the enzyme is inactivated by the gastric acid in the stomach. In the duodenum the acid pH is 
neutralized and the highly active pancreatic α-amylase takes over the process of digestion 
(Despopoulos and Silbernagl, 1991). Further digestion is done by other enzymes both from the 
pancreatic juice and from the mucosa. The end product of monosaccharides is taken up by the 
mucosal cells. Human intestinal enzymes can only hydrolyze α-glycosidic bonds (with the 
exception of lactase that hydrolyze β-glycosidic linkages between glucose and galactose 
molecules in lactose) thus cellulose and other molecules with β-glycosidic linkages arrive 
undigested to the colon. Here the undigested carbohydrates are fermented by the microbiota 
producing short chain fatty acids (SCFAs), gases and biomass. Some fermentation of the β-
glycosidic linked molecules is also done by the microbiota in the small intestine (Kutchai, 
1998;Roberfroid, 2005c). 
It is not only β-glycosidic linked molecules that arrive undigested to the colon. Usually not all of 
the ingested starch is completely digested and absorbed in the small intestine. Some is therefore 
passed on to the colon where it is fermented by the colonic microbiota (Kutchai, 1998). 
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Composition of the human gastrointestinal microbiota 
The human gastrointestinal tract is colonized by a dense and complex community of bacteria 
having a large impact on health of the host via e.g. conversion of metabolites, protection against 
pathogens and effect on the immune system and on colonic health (Vaughan et al., 2002). The 
gut is a nutrient-rich, open system with a constant temperature and flow. Because of this constant 
flow, organisms in the gut either have to attach to or colonize host tissues or to reproduce at a 
rate sufficient to avoid washout (Flint et al., 2007). 
The total estimate of microorganisms in the GI tract is approximately 1014. However, the actual 
number of bacteria differs greatly among the different regions of the GI tract with only 103 
colony forming units (cfu) per gram content in the stomach, 104-107 cfu per gram in the small 
intestine and 1010-1012 cfu per gram in the colon where the density of bacteria is highest 
(Holzapfel et al., 1998). Approximately 60% of feces is composed of bacteria (Stephen and 
Cummings, 1980). 
Previously, the composition of the microbiota has been elucidated through culturing techniques, 
however, many microbial species cannot be cultured because their preferred growth conditions 
are unknown or difficult to reproduce. Thus, research on microbial diversity is increasingly 
making use of new culture-independent techniques that classify bacteria based upon 
phylogenetic comparison of 16S rRNA sequences (Flint et al., 2007;Bik, 2009). Very recently 
the human microbiota of 124 European adults have been examined by metagenomic sequencing 
(Qin et al., 2010). By using these culture-independent techniques far more phylotypes have been 
found. Nevertheless, it is still believed that we have not characterized all of the normal human 
microbiota yet (Rajilic-Stojanovic et al., 2007). Up to now, around 1000 distinct microorganisms 
(bacteria species, as well as archaea and eukarya) have been found in the human GI microbiota 
(Rajilic-Stojanovic et al., 2007;Boesten and de Vos, 2008;Qin et al., 2010). Despite this 
enormous biodiversity, the majority of the human-associated bacteria are members of only four 
phyla, namely Firmicutes (including the large class of Clostridia and the lactic acid bacteria), 
Bacteroidetes, Actinobacteria (including Collinsella and Bifidobacterium spp.), and 
Proteobacteria. Bacteria from the two phyla Firmicutes and Bacteroidetes account for the 
majority of the bacteria in the colon (Dethlefsen et al., 2007;Qin et al., 2010). Subdominant 
groups are enterobacteriacae, streptococci, and lactobacilli. The human microbiota is dominated 
by gram-positive and aerobic bacteria (Guarner and Malagelada, 2003;Boesten and de Vos, 
2008). 
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The composition of the human microbiota is comparable to the microbiota of other mammals at 
the phylum level while most bacterial families and genera seem to be distinct (Dethlefsen et al., 
2007).  
 
The balanced microbiota 
The microbiota has a significant impact on the health of the host and an “unbalance” in the 
composition of the microbiota is thought to be a contributory factor in the development of 
several diseases e.g. acute gastroenteritis, colon cancer and more chronic disorders such as 
inflammatory bowel disease (Gibson and Fuller, 2000). Some of the colonic bacteria are thought 
to be potentially deleterious (e.g. Clostridia spp., Staphylococci spp. and Proteus spp.) and some 
potentially beneficial (e.g. Bifidobacterium spp. and Lactobacillus spp.) but the classification as 
either harmful or beneficial is often hard to make, both because of limited knowledge and 
because some bacteria genera seem to have ambiguous physiological functions (figure 4) 
(Roberfroid, 2008a).  
 
 
Figure 4: Schematic average distribution of components of human fecal microbiota divided between 
potentially deleterious and potentially beneficial groups. Some of the bacteria groups are still difficult to 
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classify as either deleterious or beneficial because of lack of knowledge. Preliminary results suggest that 
at least some members of the groups Eubacterium rectal and Cl. Leptum may be classified as beneficial 
(Roberfroid, 2008a).  
 
Positive effects have been attributed to the presence of Bifidobacterium and Lactobacillus 
predominantly present in the colon and ileum, respectively (Boesten and de Vos, 2008). 
Abundance of bifidobacteria and lactobacilli in the human microbiota has e.g. been implicated in 
protection against gastrointestinal infections and allergies (Bruzzese et al., 2006). Even though 
most research has been done on bifidobacteria and lactobacilli also other bacteria are believed to 
be beneficial to the host. Faecalibacterium prausnitzii for instance has been found to be 
underrepresented in patients with inflammatory bowel disease (Manichanh et al., 2006). 
Recently, Sokol et al. (2008) found that F. prausnitzii has anti-inflammatory properties and this 
mechanism may explain the reversed relationship between the presence of F. prausnitzii and 
inflammatory bowel disease. 
The composition of the normal so-called balanced microbiota is still insufficiently described and 
the physiological impact of some of the different genera is uncertain. The difficulties that have 
been in distinguishing the “good” bacteria from the “bad” might reflect the wide variety of 
interactions between different bacteria groups in the microbiota. Because of the large degree of 
cross-feeding and other interactions between bacteria groups some of the bacteria now 
considered harmful are maybe, in small numbers, necessary for maintaining health and well 
being of the host (Roberfroid, 2005d).  
 
Individual variation and age related changes in the human microbiota 
The major dominant bacteria groups as described above are almost always present in all 
individuals, but considerable species variations between individuals are common (Eckburg et al., 
2005;Wells et al., 2008). Qin et al., (2010) found by metagenomic sequencing a core of species 
of approximately 6% common to over 50% of the individuals tested.  
During birth the establishment of the intestinal microbiota is started. The infant composition of 
the microbiota quickly changes during the first few weeks and new bacteria species establish in 
the GI tract during the first years of life. After two years the microbiota begins to resemble the 
microbiota of an adult (Boyle and Tang, 2006). It is usually aerobic or facultative anaerobic 
Theoretical Part – The gastrointestinal tract 
 
18 
 
bacteria, like enterobacteria, enterococci and staphylococci that are the first to establish in the 
infant gut. These bacteria consume the oxygen making the way for the proliferation of anaerobic 
bacteria like Bifidobacterium, Clostridium and Bacteroides. As the oxygen concentration in the 
gut drops the number of aerobic bacteria decline (Adlerberth, 2008). Several studies have been 
made on what influence feeding mode has on the microbiota of infants, however, the literature is 
often contradictory. In spite of that there is general agreement that numbers of Clostridium 
(especially C. difficile) are lower in breast-fed infants as compared with formula-fed infants 
(Vael and Desager, 2009). 
Although the composition of the young and adult microbiota is thought to be quite stable several 
factors can influence the composition of the microbiota, among them the environment, age, 
gender and diet (Eckburg et al., 2005;Wells et al., 2008). The number and species diversity of 
beneficial bacteria such as anaerobic bacteroides and bifidobacteria are declining with age in 
conjunction with an increased number of facultative anaerobes (Mitsuoka et al., 
1974;Woodmansey et al., 2004;Bartosch et al., 2004). These changes might help explain the 
decreased gut functionality often seen in elderly people. 
 
Anaerobic fermentation of carbohydrates by the human microbiota 
The majority of colonic bacteria use carbohydrates not already digested and absorbed in the 
small intestine as their main feeding substrate. In the ascending part of the colon where the 
concentration of non-digested carbohydrates is highest the metabolism of carbohydrates is 
quantitatively more important than amino acid fermentation. Because of the increased 
fermentation the pH in this part of the colon is often lower than in the rest of the colon 
(Roberfroid, 2005b;Flint et al., 2007). The most frequently used substrates for colonic 
carbohydrate fermentation are non-starch or plant cell wall polysaccharides (including cellulose, 
pectin and polymers of e.g. glucose or xylose), oligosaccharides (e.g. inulin-fructans) and 
starches that have not been fully digested in the small intestine (Roberfroid, 2005b). The main 
fermentation end products are short chain fatty acids (SCFA) (mainly acetate, propionate and 
butyrate), ethanol, gases and intermediate metabolites (e.g. formate, lactate and succinate). 
Around 95% of the SCFA produced in the colon is absorbed by the intestinal epithelial cells 
(Cummings and Macfarlane, 1991) where they serve as energy sources for colonic epithelial 
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cells (especially butyrate), anti-inflammatory agents and regulators of gene expression. SCFAs 
therefore have a significant effect on the gut environment and on the host (Roberfroid, 2005b).  
The breakdown of carbohydrates in the colon is a complex process involving different groups of 
bacteria via metabolic cross-feeding. One group of bacteria may be able to degrade a complex 
polysaccharide resulting in the release of oligosaccharides that they do not utilize. These 
molecules can now be further digested by other groups of bacteria (Rossi et al., 2005).  
 
The gastrointestinal tract and microbiota of guinea pigs 
The anatomy of the gastrointestinal (GI) tract of guinea pigs is relatively well known. The major 
difference between the GI tract of humans and guinea pigs is the large caecum of the guinea pig 
(see figure 5). 
 
 
Figure 5: Schematic representation of the gastrointestinal system of a guinea pig. 
 
The caecum of rodents is a large thin-walled sack located in the crossing between the small 
intestine and the colon (Breazile and Brown, 1976). The caecum of humans is rudimentary and 
does not make a bulge and is simply the first part of the colon where the appendix is fixed 
(Kutchai, 1998). The caecum of rodents and guinea pigs is the major site of fermentation 
especially of plant materials such as cellulose. Humans mainly carry out fermentation in the 
colon (Kararli, 1995). This fermentation leads to a large production of SCFA and it has been 
estimated that up to 44% of the energy requirement of animals like guinea pigs with a well-
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developed caecum come from SCFA while the energy derived from SCFA in humans only 
account for 6-9% (McNeil, 1984;Leser and Molbak, 2009). Only a few studies have investigated 
the composition of the microbiota of guinea pigs (Erichsen, 1969;Yanabe et al., 2001;Takahashi 
et al., 2005). The caecal microbiota of guinea pigs has among others species been shown to 
include species of Bacteroidaceae, Eubacteria, Clostridia, Bifidobacteria, Lactobacillus and 
Enterobacteriaceae (Yanabe et al., 2001). 
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Prebiotics 
 
Pre‐ and probiotics 
The composition of the human gut microbiota can be affected by the diet. The increased 
knowledge of the human microbiota and of the considerable impact it has on the health of the 
host has led to the development of dietary components that can sustain or improve the human 
microbiota. Probiotics are one of such dietary components developed to positively affect the GI 
microbiota. Probiotics are viable beneficial microorganisms, often bifidobacteria or lactobacilli, 
presently found in many food items such as yogurt, juice or capsules (Rijkers et al., 2010). 
Prebiotics are another type of dietary component aiming at producing a beneficial effect on the 
GI microbiota. Prebiotics are dietary compounds that are nondigestible for the human body and 
therefore reach the large intestine in an intact form. In the large intestine the prebiotics are 
fermented by preferable the beneficial rather than the harmful bacteria of the microbiota 
(Bruzzese et al., 2006). Gibson et al. (2004) defined a prebiotic as “a selectively fermented 
ingredient that allows specific changes, both in the composition and/or activity in the 
gastrointestinal microbiota that confers benefits upon host well-being and health”. The focus of 
this section of the thesis will be on prebiotics. 
 
Established and putative prebiotics  
Some clear criteria need to be fulfilled for a carbohydrate to be called a prebiotic: 1. Resistance 
to gastric activity and resistance to hydrolysis by mammalian enzymes 2. No absorption in the 
upper gastrointestinal tract 3. Fermentation by the intestinal microbiota 4. Selective stimulation 
of the growth and/or activity of intestinal bacteria believed to be beneficial to the host (Gibson et 
al., 2004). The fourth criterion demonstrating selectivity is the most difficult to fulfill. 
Experiments are most correctly done in vivo, all though in vitro assays with fecal innocua often 
gives a fairly good picture of the selectivity of the carbohydrate tested (Gibson et al., 
2004;Roberfroid, 2008b). As seen from the criteria listed above not all nondigestible 
carbohydrates are prebiotics, however, many food oligosaccharides and polysaccharides have 
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incorrectly been claimed to be prebiotics without meeting the criteria (Roberfroid, 2007). So far 
only two food ingredients i.e. inulin-type fructans and galactooligosaccharide fulfill all the 
criteria to be called prebiotics (Roberfroid, 2007). In the following section inulin and 
galactooligosaccharide (also called trans-galactooligosaccharide) and three prospective prebiotic, 
xylooligosaccharides (XOS), polydextrose and apple pectin will be further discussed (table 1). 
These are the five carbohydrates that have been used in the experimental part of this thesis.  
 
Prebiotic Structure 
Degree of 
polymerization 
Production Reference 
Inulin 
Fructans joined by β(1Æ2) 
glycosidic bonds, often 
terminated by a glucose 
molecule 
Between 2 and 60. 
Average DP of 12 
Commonly extracted 
from chicory 
(Roberfroid, 
2005d) 
Galacto-
oligosaccharide 
Galactose units joint by 
β(1Æ2), β(1Æ3) or β(1Æ4) 
linkages, often terminated by a 
glucose molecule.  
Between 2 and 6 Enzymatic conversion 
of lactose. The 
intermediates lactose, 
glucose and galactose 
are often found in the 
final product 
(Macfarlane et al., 
2008;Albrecht et 
al., 2010) 
Xylo-
oligosaccharide 
Xylose units joint by β(1Æ4) 
glycosidic bonds 
Between 2 and 6 Degradation of xylan 
molecules from xylan 
rich agricultural 
residues e.g. corn cobs 
(Martin-Pelaez et 
al., 
2008;Roberfroid, 
2008b;Akpinar et 
al., 2010) 
Polydextrose 
Randomly bonded polymers of 
glucose, sorbitol and citric or 
phosphoric acid (mostly 1Æ6-
glycosidic bonds) 
Between 1 and 
100. Average DP 
of 12 
Condensation of 
glucose under high 
temperature and partial 
vacuum 
(Voragen, 
1998;Burdock and 
Flamm, 
1999;Zhong et al., 
2000) 
Apple pectin 
α(1Æ4)-linked galacturonic 
acid interspersed with few 
rhamnose units linked to 
galacturonate units with 
β(1Æ2) and β(1Æ4) bonds 
Large, complex 
molecule. DP > 2 
Commonly extracted 
from apple pomace. 
(May, 1990;Caffall 
and Mohnen, 2009) 
Table 1: Structure, degree of polymerization and typical production methods for inulin, 
galactooligosaccharide, xylooligosaccharide, polydextrose and apple pectin. 
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Inulin 
Inulin is naturally found in a large variety of plants that uses inulin as a mean of storing energy 
(Roberfroid, 2005d). Inulin is resistant to hydrolysis by the human enzymes in the small intestine 
because the fructose monomers are linked by β(2Æ1) glycosidic bonds. Both in vitro and in vivo 
testing have confirmed that inulin reach the large intestine undigested (Roberfroid, 1993) and 
extensive in vitro culture fermentation studies and human trials have shown that inulin 
selectively stimulate the growth of bifidobacteria and lactobacilli (Wang and Gibson, 
1993;Gibson and Wang, 1994;Bouhnik et al., 1996;Tuohy et al., 2001). Moreover, human trials 
have shown that addition of inulin and galactooligosaccharides to formula of infants results in an 
increase in bifidobacteria and lactobacilli (Moro et al., 2002;Boehm et al., 2002). This is 
consistent with data showing that bifidobacteria are able to break down and utilize inulin by the 
action of their β-fructofuranosidase enzyme (Manzanares and Hardy, 2008).  
 
Galactooligosaccharide 
Galactooligosaccharides (GOS) are oligosaccharides naturally occurring in human breast milk 
(Kunz et al., 2000). No studies have undoubtedly shown that GOS reach the colon without being 
hydrolyzed by the human enzymes in the small intestine (Roberfroid, 2007). A number of in 
vitro studies and human trials investigating the influence of GOS on the microbiota have shown 
that GOS has a positive effect on the number of lactobacilli and in an even higher degree on the 
number of bifidobacteria combined with a unchanged or decreased number of enterobacteria 
(Minami et al., 1983;Rowland and Tanaka, 1993;Ito et al., 1993;Bouhnik et al., 1997). As stated 
in the previous paragraph human trials with infants shows an increase in the fecal number of 
bifidobacteria when a mixture of GOS and inulin is added to the infants formula milk (Moro et 
al., 2002;Boehm et al., 2002).   
The convincing data from the human studies imply that GOS are considered a prebiotic 
(Roberfroid, 2008b).  
 
Xylooligosaccharide 
Xylooligosaccharides (XOS) are usually made by degradation of xylan rich molecules. Xylan are 
naturally found in e.g. birchwood, beechwood, corncob, and oat spelt (Akpinar et al., 2009). No 
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data exist to confirm that the xylooligosaccharides resist the digestive processes in the gut and 
small intestine, however, xylan is defined as a dietary fiber suggesting that it may reach the 
colon intact (Roberfroid, 2008b). Moreover, XOS is stable over a wide range of pH even at the 
relatively low pH of the gastric juice (Vazquez et al., 2000). Several in vivo and in vitro studies 
have shown a positive stimulation of the growth of bifidobacteria by XOS but so far failed to 
show a convincing selective stimulation of bacterial growth (Campbell et al., 1997;Jaskari et al., 
1998;Vazquez et al., 2000;Martin-Pelaez et al., 2008) 
Scientific evidence still needs to be published before XOS can be regarded as a prebiotic and it 
will therefore be more correct to classify it as an “emerging prebiotic”. 
 
Polydextrose 
Polydextrose is an artificial made polysaccharide with no natural occurrence. Polydextrose is 
used in the food industry as a replacement for fat and sucrose providing only 25% of the caloric 
value of sucrose (Voragen, 1998;Burdock and Flamm, 1999). Because of the high molecular 
weight and the complexity of polydextrose it is almost intact when it reaches the colon where it 
is partially digested by the indigenous microbiota (Burdock and Flamm, 1999).  
Conflicting data exist about the effect of polydextrose on the composition of the microbiota. 
Probert et al (2004) and Hernot et al (2009) found by in vitro fermentation studies that 
polydextrose had positive effect on the number of bifidobacteria. Similarly, Zhong et al (2000) 
found in a human trial that intake of polydextrose increase the number of bifidobacteria and 
lactobacilli in fecal samples, while the number of bacteroides decrease. Contrary, Fava et al 
(2007) and Hengst et al (2009) found no effect of intake of polydextrose on the number of 
bifidobacteria and lactobacilli in pigs intestinal content and in fecal samples from humans, 
respectively.  
Because of the lack of compelling scientific data from human trials polydextrose is not presently 
regarded as a prebiotic. 
 
Apple pectin 
Pectin is found in the primary cell wall of plants and is the traditional gelling agent for jams and 
jellies. Pectin is also used in the food industry e.g. in fruit products and dairy products (May, 
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1990;Caffall and Mohnen, 2009). Pectinases and pectolytic enzymes that hydrolyse pectin are 
widely distributed in higher plants and microorganisms. Pectins are defined as a dietary fiber and 
as other dietary fibers pectin is not digested in the small intestine and therefore reach the large 
intestine intact (Cummings and Englyst, 1987;Mandalari et al., 2007). Several in vitro studies 
have shown that pectins increase the number of bifidobacteria and lactobacilli (Crociani et al., 
1994;Olano-Martin et al., 2002;Mandalari et al., 2007). Olano-Martin et al (2002) found that 
oligosaccharides derived from pectin have a greater impact on the growth of bifidobacteria than 
pectins. Besides the positive effect on the number of bifidobacteria and lactobacilli, pectin has 
also other positive physiological effects in the gastrointestinal tract. These include delayed 
gastric emptying and reduced glucose absorption, both characters thought to be due to the gel 
forming and water holding capacity of pectin (Olano-Martin et al., 2002). 
On the basis of the data obtained through in vitro fermentations, pectins exhibit potential to be 
classified as a prebiotic, however, human trials have to be conducted to confirm the in vitro data.  
 
Prevention of gastrointestinal infections with prebiotics 
Besides being the place for the initial digestion and absorption of nutrients the gut also has a very 
important function in defending the host against infections with ingested pathogenic bacteria. A 
number of studies have shown that intake of prebiotics can help to prevent infections with 
pathogenic bacteria. Several mechanisms appear to be involved and they can roughly be divided 
into microbiota-dependent and microbiota-independent mechanisms. These mechanisms will be 
addressed in the following section.  
 
Microbiota dependent mechanisms 
Lactic acid bacteria have been shown to protect against infection with L. monocytogenes both in 
vitro and in vivo. Thus the in vitro invasion of L. monocytogenes into intestinal cell lines has 
been inhibited by a number of lactic acid bacteria (Altenhoefer et al., 2004;Corr et al., 2007). 
Administration of live Lactobacillus strains prior to challenge with L. monocytogenes has been 
shown to significantly protect mice against infection (Bambirra et al., 2007;Vieira et al., 2008). 
The idea is that prebiotics help protect the host against pathogenic infections by increasing the 
density and metabolic activity of the beneficial bacteria of the indigenous microbiota. Several 
Theoretical Part – Prebiotics 
 
26 
 
mechanisms are thought to be involved in this microbiota-dependent protective effect of 
administration of prebiotics. It is believed that stimulation of the beneficial bacteria leads to an 
increased competition for nutrients and adhesion sites with the pathogen, increased production of 
SCFA and bacteriocins harmful for the pathogen and stimulation of the immune system 
(Bourlioux et al., 2003). 
 
Competition for nutrients 
It is a common mechanism that the bigger the indigenous microbiota of any given ecological 
niche the harder it will be for an outside bacterium, whether pathogenic or nonpathogenic, to 
establish itself in the microbiota (Wells et al., 2008). Fewer nutrients will be available and this 
will start a strong competition where only those bacteria most efficient at utilizing the nutrients 
will survive. It can therefore be hypothesized that for a prebiotic to be most effective, it has to be 
administered in advance before the pathogen is introduced giving the prebiotic time to stimulate 
the growth of the indigenous bacteria (Wells et al., 2008). 
Bifidobacteria can grow on a range of different prebiotics (inulin, fructooligosaccharides (FOS), 
GOS, XOS and pectin) (Wang and Gibson, 1993;Rowland and Tanaka, 1993;Campbell et al., 
1997;Olano-Martin et al., 2002). However, bifidobacteria are especially good at fermenting 
inulin and FOS. This is due to the ability of the bifidobacteria to produce β-fructofuranosidase 
and a special transport system that helps the bifidobacteria take up FOS with a DP below 8 
(Janer et al., 2004). Bifidobacteria are believed to hydrolyze inulin and FOS at the cell surface 
and degrade the shorter molecules intracellularly so that no intermediate products are released to 
the surroundings and by that to the competing bacteria (Bosscher et al., 2006). The ability of 
pathogenic bacteria to utilize prebiotics is an area that has been given relatively little focus 
(Fooks and Gibson, 2002;Petersen et al., 2009). 
 
Production of short‐chain fatty acids 
The fermentation of prebiotics by bifidobacteria and lactobacilli in the colon leads to the 
production of short-chain fatty acids (SCFA) and to the production of gases (CO2, H2 and CH4). 
The SCFA produced depend on the type of substrate fermented although the SCFA most often 
produced is acetate, propionate and butyrate, while lactate, ethanol, succinate, formate, valerate 
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and caproate are produced in smaller amounts (Mountzouris et al., 2002). SCFA in the colon 
affect the potential for pathogenic bacteria to induce infection in several ways. Increased 
production of SFCA lead to acidification of the colon making growth difficult for some 
pathogenic bacteria (Wang and Gibson, 1993;Fooks and Gibson, 2002;Bosscher et al., 
2006;Louis et al., 2007). Lactic-acid producing bacteria are generally very acid tolerant and 
hence, their growth is less affected. This acidification also results in increased mucin production 
believed to improve mucosal morphology and by that decreasing the colonization and 
translocation of pathogenic bacteria (Barcelo et al., 2000;Lomax and Calder, 2008). SCFA are 
also known to affect the immune system and in that way to influence the infective potential of 
pathogenic bacteria (Lomax and Calder, 2008).  
 
Production of bacteriocins 
Bacteriocins are antimicrobial peptides or proteins produced by strains of diverse bacterial 
species in response to the presence of other bacteria. Bacteriocins have a relatively narrow 
killing spectrum and are often only toxic to bacteria closely related to the strain producing them 
(Wells et al., 2008). Some of the colonic strains of bifidobacteria and lactobacilli have been 
found to produce bacteriocins and this may give them a competitive advantage within the 
complex ecosystem of the gut (Servin, 2004). Bacteriocins produced by bifidobacteria and 
lactobacilli have been shown to be active against pathogenic bacteria such as strains of Listeria, 
E. coli, Salmonella and Clostridia (Ferreira and Lund, 1996;Zamfir et al., 1999;Casadei et al., 
2009;Slavica et al., 2010). The mechanism of action for many bacteriocins is to form pores in the 
cytoplasmic membrane of the target bacteria and in that way dissipate the proton motive force. 
Other bacteriocins work by interfering with essential proteins of the target bacteria (Servin, 
2004). Bacteriocins are nontoxic to eukaryotic cells and are generally recognized as safe 
substances. Comprehensive research in the use of bacteriocins as natural food preservatives is 
done by the food industry. Yet, the only bacteriocin used commercially is nisin produced by 
strains of Lactococcus lactic (Galvez et al., 2008). Chen et al (2007) found in an in vitro assay 
that FOS directly induce bacteriocin production from selected strains of Lactobacillus and 
Lactococcus.  
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Competition for adhesion sites 
Adherence to the intestinal cells is considered a very important step in the infection cycle for 
most pathogen bacteria. Without adherence the pathogenic bacteria cannot withstand the flow of 
the intestinal chyme and they are rapidly eliminated from the intestine (Lee et al., 2003). A 
prebiotic stimulation of the indigenous bacteria population leading to increased occupation of 
intestinal adherence sites and thereby inhibition of the adherence of pathogens is therefore 
thought to be one of the mechanisms that underlies the positive effects of prebiotics against 
pathogenic bacteria. Several in vitro studies have shown that strains of bifidobacteria and 
lactobacilli can inhibit, displace and compete with the adherence of pathogens such as L. 
monocytogenes, E. coli and S. Typhimurium to intestinal cell lines and intestinal mucus 
(Tuomola et al., 1999;Lee et al., 2003;Collado et al., 2005;Collado et al., 2006). 
 
Microbiota independent mechanisms 
Most of the protective effect of prebiotics is believed to go through stimulation of beneficial 
bacteria from the indigenous microbiota. However, it has also been discovered that prebiotics in 
itself can exert some protective mechanism against infection with enteric pathogens. 
 
Attenuation of virulence 
It has been suggested that adherence inhibition by prebiotics may be due to modulation of the 
virulence genes of the pathogen (Knutton et al., 1997;Vanmaele et al., 1999;Shoaf et al., 2006). 
Regulation of virulence genes by the presence of carbohydrates in the growth media has been 
seen for a number of bacteria (Ankenbauer and Nester, 1990;VanGijsegem, 1997;Brencic and 
Winans, 2005) including L. monocytogenes (Park and Kroll, 1993;Milenbachs et al., 
1997;Gilbreth et al., 2004). The repression of virulence genes in L. monocytogenes could either 
be because the prebiotic molecules functioned as a signaling molecule per se or more likely be a 
result of catabolite repression (see paragraph “Carbohydrates and gene expression in L. 
monocytogenes”). 
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Receptor decoy 
Certain carbohydrates structurally resemble the saccharide-containing glycoproteins that many 
pathogens bind to on the intestinal cell (Kunz et al., 2000). This has lead to the hypothesis that 
some carbohydrate may act as an intestinal receptor decoy for pathogenic bacteria by mimicking 
the host cell receptor on the intestinal cell that the pathogen normally adhere to. By binding to 
the carbohydrate instead of to the intestinal cells the pathogen is washed from the gastrointestinal 
tract and has little chance of invading the body. This has been confirmed in several in vitro 
studies where the ability of several carbohydrates to inhibit the adherence and invasion of 
pathogenic bacteria has been studied (Tzortzis et al., 2005;Shoaf et al., 2006;Rhoades et al., 
2006;Rhoades et al., 2008;Searle et al., 2009). The inhibition of adherence is strain dependent 
and some of these studies have shown that some carbohydrates can have no or the opposite effect 
of what was intended and instead enhanced the adherence (Ruas-Madiedo et al., 2006;Searle et 
al., 2009). 
 
Microbiota dependent and independent mechanism 
 
Immunomodulation 
The intestine is the largest immune system in the body. It is estimated that the intestine contains 
approximately 80% of all antibody-producing cells and produces antibodies more efficiently than 
any other part of the body (Fukasawa et al., 2007). The diet and the digestion products are in 
close contact with the intestinal immune system including the gut-associated lymphoid tissue 
(GALT). Even though data from human studies are still scarce, data from animal studies clearly 
indicate that the diet can modulate immune functions in multiple ways (Watzl et al., 
2005;Lomax and Calder, 2008). The prebiotics exert their influence on the immune system both 
directly by interacting with carbohydrate receptors on immune cells and indirectly by increasing 
the number of lactic acid producing bacteria. The increase in lactic acid producing bacteria 
changes the presence of various immunomodulating molecules such as endotoxins, 
lipopolysaccharides and SCFA (Watzl et al., 2005). This leads to beneficial changes in the 
immune system such as modulation of immune cells in Peyer´s patches (Hosono et al., 
2003;Manhart et al., 2003), increased cytotoxicity of natural killer cells (Kelly-Quagliana et al., 
2003) and increased production of IgA and various interleukins (Hosono et al., 2003).  
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Prebiotics and infection studies in animals 
The majority of animal and human studies investigating the effects of prebiotics on susceptibility 
to infection have been carried out using inulin and fructooligosaccharides (FOS) (Lomax and 
Calder, 2008). 
Most animal studies have been conducted on mice, rats and pigs and the effect of prebiotics have 
been investigated on a number of pathogenic bacteria including Escherichia coli (Bunce et al., 
1995) Clostridium difficile (Wolf et al., 1997), Salmonella typhimurium (Letellier et al., 
2000;Buddington et al., 2002;Correa-Matos et al., 2003;Petersen et al., 2009), Salmonella 
enteritidis (Ten Bruggencate et al., 2003;Bovee-Oudenhoven et al., 2003;Ten Bruggencate et al., 
2004) and L. monocytogenes (Buddington et al., 2002). These studies generally provide evidence 
to support the hypothesis that prebiotics improve host resistance to bacterial infections. This 
emerges as prevention of diarrhea, decreased colonization and translocation of the pathogen and 
increasing animal survival rates. 
However, a series of publications by a single group of investigators have investigated the effect 
of FOS and inulin on infection with S. enteritidis in rats on a low-calcium diet (Ten Bruggencate 
et al., 2003;Bovee-Oudenhoven et al., 2003;Ten Bruggencate et al., 2004;Ten Bruggencate et 
al., 2005). Despite an increase in the number of faecal lactobacilli and bifidobacteria, increased 
colonization and translocation of S. enteritidis and increased mucosal irritation was seen in these 
studies. Acidification of the intestine has been shown to be counteracted by dietary calcium 
(Govers et al.  1993). The adverse effect in these studies could be reversed by oral administration 
of calcium and it was therefore suggested that the increased translocation of S. enteritidis could 
be connected to low pH (Bovee-Oudenhoven et al., 1997;Ten Bruggencate et al., 2004). 
Roberfoid gives a thorough discussion of these experiments and conclude that they do not 
demonstrate that FOS and inulin stimulate translocation in rats on a normal diet (Roberfroid, 
2005a). A recent study by a different group showed increased translocation of S. typhimurium in 
mouse fed a normal-calcium diet supplemented with FOS (Petersen et al., 2009). However, in 
this study no decrease in intestinal pH was observed, contradicting that a drop in pH suggested 
by ten Bruggencate et al and Bovee-Oudenhoven et al should mediate the increased translocation 
of Salmonella. 
Only one previous study have addressed the effect of prebiotics on the infectivity of L. 
monocytogenes (Buddington et al., 2002). After 6 weeks on a diet supplemented with either 
Theoretical Part – Prebiotics 
 
31 
 
inulin or FOS, mice were given a systemic infection with L. monocytogenes by intraperitoneal 
injection. This way of infecting the animals bypasses the gastrointestinal tract and by that the 
common starting site of L. monocytogenes infections. Nevertheless, feeding with inulin or FOS 
induced a significant decrease in mortality and it was speculated that the mechanistic basis for 
the increased resistance could be due to a stimulation of the immune response caused by changes 
in the intestinal bacterial composition (Buddington et al., 2002).  
 
Prebiotics and infection studies in humans 
The ability of prebiotics to protect against infection with pathogenic bacteria is more difficult to 
study in human subjects than in animals since challenge studies are of course not ethically 
allowed. However, some studies both in children and adults have been conducted up to now. 
Studies in infants and children have shown a decrease in the incidence of common childhood 
diarrhoea after prebiotic supplementation (Waligora-Dupriet et al., 2007;Bruzzese et al., 2009). 
Other studies have failed to show an effect of prebiotics on frequency of common childhood 
diarrhoea but have instead seen a decrease in the duration or severity of the infections (Saavedra 
et al., 1999;Tschernia et al., 1999;Juffrie, 2002). Taken together, data from these studies suggest 
that prebiotics can be used in the prevention and treatment of some infections in infants and 
children.  
Studies in adults are more limited and less convincing compared with the studies made in infants 
and children. A few studies have investigated the effect of prebiotics on reducing the incidence 
of travellers´ diarrhoea (Cummings et al., 2001;Drakoularakou et al., 2010). Drakoularakou et 
al., (2010) observed a significantly lower number of episodes with diarrhoea when the subjects 
consumed GOS prior to and during their holiday. Nevertheless, a study of Cummings et al., 
(2001) showed no effect of FOS supplementation on the incidence of travellers´ diarrhoea. A 
study including in-patients with C. difficile-associated diarrhoea showed a decrease in relapse 
rates when patients received a diet supplemented with FOS (Lewis et al., 2005a). However, a 
study where elderly patients were given a diet supplemented with FOS showed no protection 
against antibiotic-associated diarrhoea, whether caused by C. difficile or other bacteria (Lewis et 
al., 2005b). 
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Although more human studies needs to be done before any clear conclusion can be drawn, 
evidence from both animal and human studies accumulate to suggest that consumption of some 
prebiotics can reduce the incidence or duration of some infections in children and adults. 
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Discussion 
This study presents an investigation of the effects of different non-digestible carbohydrates 
(putative prebiotics) on the infective potential of L. monocytogenes. 
It was found that feeding guinea pigs with inulin and apple pectin promoted L. monocytogenes 
infection, while xylooligosaccharide (XOS) and galactooligosaccharide (GOS) prevented it. No 
effect was seen after feeding the guinea pigs with polydextrose (manuscript I). 
Several studies have suggested that short chain carbohydrates are fermented more rapidly with 
greater bifidogenic effect than carbohydrates with longer chain length (DP>10) (Livesey et al., 
1993;de, V et al., 2008;Hernot et al., 2009). XOS and GOS both have a degree of polymerization 
between 2 and 6 while the three other carbohydrates tested all have a greater degree of 
polymerization. It is therefore striking that XOS and GOS also are the two carbohydrates 
preventing L. monocytogenes infection in guinea pigs. Because of the short chain length it could 
therefore be speculated that the fermentation of XOS and GOS by the microbiota already starts 
in the small intestine. Many gut infections, including infection with L. monocytogenes, occur in 
the small intestine. However, the microbiota-dependent effect of prebiotics is generally believed 
to be limited in the small intestine since the fermentation of prebiotics mainly occurs in the colon 
where the bacteria density is highest. However, if the fermentation of XOS and GOS, because of 
their low DP, already starts in the small intestine the number of beneficial bacteria might 
increase explaining why it is only XOS and GOS that have been found to prevent infections with 
L. monocytogenes in guinea pigs. XOS and GOS might also in themselves or through stimulation 
of lactobacilli and bifidobacteria have a larger impact on the immune system than the other three 
carbohydrates. This could be a systemic stimulation of the immune system, independent of the 
site of prebiotic fermentation.  
In this study XOS was found to have a protective effect against infections with L. 
monocytogenes, however it has recently been demonstrated that XOS increased the translocation 
of Salmonella Typhimurium in mice (Petersen et al., 2009). This indicates that the prebiotic 
effect is dependent on the pathogenic species tested and probably also on the animal model used. 
Feeding the guinea pigs with XOS and polydextrose led to a drop in caecal pH. This indicates a 
change in the fermentation pattern and a change in the composition of the microbiota. Faecal 
samples were obtained from the guinea pigs before and after feeding with prebiotics. Future 
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examination of the composition of the guinea pig microbiota in these samples would give us 
information about what effect the carbohydrates have on the composition of the microbiota. This 
could possibly help explain some of the observed in vivo effects seen in the infection assay. 
Relatively little is known about the microbiota of guinea pigs. Examination of the microbiota of 
guinea pigs will give us the opportunity to compare with the microbiota of humans. This might 
strengthen our ability to interpret the results from the guinea pig infection study and to predict 
what impact the prebiotics will have on enteric infections in humans. 
So far, only one study has investigated the effect of prebiotics on the infective potential of L. 
monocytogenes (Buddington et al., 2002). Contradictory to my results, Buddington et al. 
reported that feeding with inulin substantially reduced the mortality rate of mice after infection 
with L. monocytogenes. However, the setup of the two experiments is quite different and the 
results are therefore difficult to compare. Different L. monocytogenes strains, different animal 
models, different way of infecting the animals and different ways of measuring the infectivity of 
L. monocytogenes were used in the two studies. All factors that potentially could have an impact 
on the outcome of the experiments.  
It has up to now been believed that InlB was not involved in the intestinal phase of the listerial 
infection. In this study we primary wanted to investigate the intestinal phase of L. 
monocytogenes infection and guinea pigs compared with mice were therefore the obvious choice 
as animal model. However, a recent study suggests that InlB might be involved in the intestinal 
phase of the L. monocytogenes infection (Pentecost et al., 2010). More studies are needed to 
further elucidate which role InlB plays in the gastrointestinal colonization and invasion of L. 
monocytogenes. This might provide a background for an evaluation of the relevance in using 
guinea pigs in future studies of L. monocytogenes. 
The attention has recently been drawn to the gerbil as an animal model for listeriosis (Disson et 
al., 2008). The gerbil is naturally susceptible to L. monocytogenes and was one of the first 
animals from where L. monocytogenes was isolated (Pirie, 1927). The biology of gerbils is not 
thoroughly elucidated, but according to Disson et al the gerbil is easy to work with and give 
robust results (Disson et al., 2008;Disson et al., 2009). More infection studies with the gerbil are 
needed but it has, together with the knock-in E16P mouse line, potential to be the future choice 
of animal model for infection studies with L. monocytogenes. 
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The guinea pigs were in this present study given a diet supplemented with 10% of the prebiotics. 
Most animal infection studies use between 6-16% of prebiotics in the diet (Bubbington et al., 
2002;Ten Buggencate et al., 2004;Petkevicius et al., 2007;Petersen et al., 2009). This greatly 
exceeds the maximum dose of prebiotics of 20 g/day that is generally recognized as safe for 
humans (Douglas and Sanders, 2008). However, this high dose is used to reduce the risk of 
missing a prebiotic effect because the dose is too small. If a positive prebiotic effect is observed 
randomized clinical trials have to be conducted with a smaller amount of prebiotic to confirm 
beneficial effects in humans and to demonstrate the absence of harmful effects. 
 
To further explore the mechanisms behind the effects observed in vivo the microbiota-
independent effects of the same four indigestible carbohydrates were investigated (manuscript 
II). It should be noted that apple pectin was not included in the adherence assay and the qPCR 
analyses since it formed a gel-structure when it was dissolved in water. 
When XOS was added immediately prior to the start of the adherence assay the adherence of 
strain 7291 and ScottA, but not of strain 4446 to tissue culture cells was inhibited. As the only 
strain of the three L. monocytogenes strains, 4446 is capable of fermenting XOS. It could be 
speculated that strain 4446 rapidly takes up XOS and in that way prevents it from sticking to the 
cell surface blocking adherence to the intestinal cells. These results suggest that XOS might act 
as a receptor decoy for L. monocytogenes strain 7291 and ScottA preventing attachment to the 
intestinal enterocytes. This might help explain the decrease in the severity of L. monocytogenes 
infection seen in guinea pigs fed with XOS. GOS also prevented infection with L. 
monocytogenes in vivo, however, no effect of this carbohydrate was seen on the in vitro 
adherence of L. monocytogenes to intestinal cells. Different mechanisms may therefore be 
responsible for the preventive effect of XOS and GOS seen in guinea pigs. 
It has previously been shown that prebiotics not only are capable of preventing in vitro 
adherence of pathogens but also of increasing the adherence (Searle et al., 2009). However, 
despite the increased infectivity after inulin feeding, inulin had no effect on the adherence of L. 
monocytogenes in vitro. Polydextrose had no effect in vivo or in vitro. 
The theory behind the anti-adherence effect of some prebiotics is based on the observation that 
many pathogens utilize saccharide-containing glycoproteins as their cellular adhesion receptor 
on the surface of intestinal cells. The prebiotics might work as a receptor decoy for the bacteria 
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preventing it from binding to the intestinal cells. This may very well be correct, however, to my 
knowledge no studies have so far investigated the possibility that the prebiotic instead of binding 
to the bacteria binds to the intestinal cell and in that way blocks the adherence of the bacteria. To 
investigate this, the intestinal cells could be pre-incubated with the prebiotic followed by a 
thorough washing before adding the bacteria.  
qPCR was used to investigate if incubation of L. monocytogenes with the carbohydrates could 
affect expression of genes known to be involved in the intestinal adherence and invasion of L. 
monocytogenes. The expression profile of strain 7291 was highly different from the expression 
profile of strain 4446 and ScottA that were very similar. The four prebiotics had an effect on 
most genes of strain 4446 and ScottA while the only gene significantly affected in strain 7291 
was iap. The adherence of all three strains of L. monocytogenes was reduced after two hours of 
incubation with XOS and subsequently removal of the carbohydrate, thus the unique expression 
profile of 7291 was not reflected in the in vitro adherence assay. Strain 7291 also separated itself 
from strain 4446 and ScottA in other ways. In the infection assay strain 7291 was slightly more 
predominant in the intestine and organs than strain 4446 and ScottA. However, feeding the 
guinea pigs with the carbohydrates did not result in a different distribution in the intestine or 
relative translocation of the three strains compared with the control groups. Furthermore, in the 
fermentation assay strain 4446 was able to utilize all the five tested carbohydrates, ScottA could 
utilize all except XOS and polydextrose while strain 7291 only was able to utilize GOS. It could 
therefore be speculated that the different expression profile of strain 7291 might somehow be 
explained by the lack of ability to ferment most of the carbohydrates. It should be noted that the 
growth OD was comparable for the three strains after two hours of incubation with the 
carbohydrates. This indicates that all of the three strains still used the glucose present in the 
media as growth substrate. 
The expression of inlA of strain 4446 and ScottA were down regulated by all of the four 
prebiotics. However, XOS had the strongest effect on inlA expression. This correlates with data 
from the adherence assay showing that only XOS reduces the adherence of L. monocytogenes to 
the intestinal tissue culture cells. InlA is known to be the principal protein involved in the 
adherence of L. monocytogenes to intestinal cells. It has previously been shown that a correlation 
exists between the level of inlA expression and the invasion capacity into Caco-2 cells 
(Werbrouck et al., 2006). It could be speculated that the expression of inlA has to be reduced 
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below a certain level before it results in reduction of the adherence in the in vitro adherence 
assay.  
Also other adherence genes were affected by the presence of the carbohydrates. It is very likely 
interactions between different proteins that are responsible for the ability of L. monocytogenes to 
adhere to the intestinal cells. However, the exact role and interplay of all the different proteins 
observed to be involved in adherence of L. monocytogenes to intestinal cells is not yet 
elucidated. Nonetheless, incubation with the carbohydrates changed the expression of most of 
the tested genes of strain 4446 and ScottA and this change in expression might be one of the 
explanations of the prebiotics effects seen in vivo. 
However, these experiments were done in vitro and nothing is known about what impact these 
carbohydrates will have in vivo on expression of adherence genes in L. monocytogenes. It could 
therefore be interesting to examine the expression of L. monocytogenes adherence genes in 
intestinal samples taken from guinea pigs fed with prebiotics. Nevertheless, because of quick 
degradation of mRNA it might be difficult to investigate the gene expression in vivo. However, 
instead of looking at the gene expression it might be possible e.g. by Western blotting to look at 
the protein expression in vivo. 
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Conclusion 
Experiments in the present study show that some carbohydrates promote and some carbohydrates 
protect against infection with L. monocytogenes in guinea pigs. The data furthermore suggest 
that dietary carbohydrates may alter the infective potential of L. monocytogenes by affecting the 
expression of adhesion-related genes, as well as through directly sticking to the bacterial surface. 
This means that certain dietary carbohydrates may prevent L. monocytogenes infections through 
other mechanisms than merely a beneficial effect on the gut microbiota.  
The carbohydrates probably affect several mechanisms that all in their way influence the 
infective potential of L. monocytogenes. It is the sum of these changes that result in the effect 
seen in the guinea pig infection assay. Results from this present study furthermore suggest that 
the mechanisms implicated are very dependent on the strain and carbohydrate involved.  
This study supports the hypothesis that some prebiotics can be helpful in the prevention of 
intestinal infections. The dietary use of prebiotics holds much potential, however, this study also 
shows that it is not safe to automatically assume that prebiotics only have positive or no effects 
on the infectivity of pathogens in the intestine.  
More knowledge about the underlying mechanisms responsible for the positive and negative 
effects of prebiotics on the infective potential of pathogens might lead to selection and 
development of prebiotics with increased effect against enteric pathogenic bacteria.  
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Abstract 
Dietary prebiotics carbohydrates are defined by a beneficial effect on the intestinal microbiota. 
However, they might also have effects that are not attributed to changes in the commensal 
bacterial community of the gut. In a previous study, we observed that certain carbohydrates 
promoted L. monocytogenes infection in guinea pigs, while others prevented it. The purpose of 
the present study was to address microbiota-independent effects of the same four indigestible 
carbohydrates which could explain the observed effects. We investigated the ability of 
xylooligosaccharides (XOS), galactooligosaccharides (GOS), inulin and polydextrose to inhibit 
the adherence of three different strains of L. monocytogenes to Caco-2 cells in vitro as well as to 
affect expression of selected virulence genes in these pathogens. Mixing with XOS significantly 
(P<0.05) decreased the ability of two of the three strains of L. monocytogenes to adhere to the 
Caco-2 cells. Additionally, 2 hours incubation with XOS followed by washing of the bacteria 
significantly (P<0.05) decreased the adherence of all three strains of L. monocytogenes to Caco-2 
cells. Expression of several L. monocytogenes genes known to be involved in adherence to 
intestinal cells (inlA, lap, ami, iap, aut, fdpA, actA) were affected in a strain dependent manner 
by the presence of these indigestible carbohydrates in the growth media. Our results show that 
certain dietary carbohydrates may prevent pathogenic infections through other mechanisms than 
a beneficial effect on the gut microbiota.   
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1. Introduction 
 
Prebiotics are currently defined as selectively fermented carbohydrates that cause specific 
changes in the gastrointestinal microbiota, resulting in beneficial effects on host health (Gibson 
et al., 2004). One such effect is the suppression of pathogenic infections, which is proposed to 
occur via one of several mechanisms. Prebiotics enrich for specific members of the intestinal 
community that produce anti-pathogenic compounds (Gibson and Wang, 1994;Drider et al., 
2006), lower the intestinal pH (Drago et al., 1997), compete for nutrients, block mucosal 
adhesion sites, and stimulate the immune system (Rhoades et al., 2008).  
While these modes of action are dependent on the carbohydrate’s effect on the surrounding 
intestinal microbiota, only few studies have addressed direct (i.e. microbiota-independent) 
effects of prebiotics on the infective potential of pathogens, and most have focused on gram-
negative bacteria (Shoaf et al., 2006;Ruas-Madiedo et al., 2006;Rhoades et al., 2008;Searle et 
al., 2009). Prebiotics may have direct inhibitory effects by blocking the mucosal adhesion sites 
recognized by enteric pathogens. The anti-adherence effect of some prebiotics is based on the 
observation that these carbohydrates structurally resemble the saccharide-containing 
glycoproteins present on the surface of intestinal cells and to which pathogens adhere (Kunz et 
al., 2000). Thus, the carbohydrates act as a receptor decoy, interfering with the attachment of the 
pathogen to the intestinal mucosa, explaining the inhibition of pathogen adhesion seen in the 
presence of oligosaccharides in most of these assays (Shoaf et al., 2006;Ruas-Madiedo et al., 
2006;Rhoades et al., 2008;Searle et al., 2009).  
We have previously shown that L. monocytogenes infection of guinea pigs was prevented by 
dietary supplementation with xylooligosaccharides (XOS) or galactooligosaccharides (GOS), but 
promoted by inulin and unaffected by polydextrose (Ebersbach et al., 2010). The purpose of the 
present study was to determine whether interactions between the pathogens and the 
carbohydrates could explain these observations.  
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2. Materials and methods 
 
2.1. Bacterial strains and culture conditions 
Three L. monocytogenes isolates were used: Strain 7291, serogroup 4b, isolated from a chicken 
pasta salad, the clinical isolate 4446, serogroup 4b, isolated from a 63-year-old female with 
septicaemia (Larsen et al., 2002), and the clinical reference isolate ScottA, serogroup 4b. All 
three strains carried nalidixic acid resistance and all also carried the plasmid pJEBAN3 coding 
for yellow fluorescent protein (YFP) and erythromycin resistance (Andersen et al., 2006). 
Bacteria were cultivated on brain heart infusion (BHI) agar (Oxoid) or in liquid BHI (Oxoid). 
When appropriate, nalidixic acid (Sigma) or erythromycin (Sigma) were used at a final 
concentration of 100 µg/ml or 10 µg/ml, respectively. 
 
2.2. Prebiotic oligosaccharides 
Inulin (BENEO ST-gel; DP 2-6, purity >90%) was kindly provided by Alsiano (Birkerød, 
Denmark), while GOS (DP 2-6, food grade purity) and polydextrose (Litesse Ultra®; average 
DP of 12, food grade purity) were kindly provided by Danisco (UK) Limited, Redhill, United 
Kingdom. XOS (DP 2-6, purity >90%) was kindly provided by Lenzing AG, Lenzing, Austria. 
 
2.3. Caco-2 cell culture 
The human colon adenocarcinoma cell-line Caco-2 was obtained from the American Type 
Culture Collection (LGC Promochem, Sweden; ATCC no. HTB-37) and maintained under tissue 
culture conditions in Dulbecco´s modified Eagle´s minimal essential medium (Gibco-BRL) 
supplemented with 10% fetal bovine serum (Fischer) and 100U/ml Penicillin G. The Caco-2 
cells were seeded at 3 x 105 cells ml-1 in 24-well tissue culture plates with and without 12-mm 
diameter glass coverslips. The Caco-2 cells were fully differentiated for 14 days by changing the 
culture medium every 2-3 days before used in infection assays. At late confluency, these cells 
express both structural and functional characteristics of enterocytes present in the small intestine 
(Halpin et al., 2009). Maintenance of cells and subsequent experiments were carried out at 37ºC 
in a humidified atmosphere of 95% air and 5% CO2. The Caco-2 cells were used between 
passage number 15 and 25.  
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2.4. Mixing of L. monocytogenes with carbohydrates 
Anaerobically-grown overnight cultures (20 mL) of each Listeria strain (7291, 4446 or ScottA)  
were harvested, washed and the pellet was resuspended in 40 ml preheated DMEM/10% FBS. 
4.5 ml of the suspension was mixed with 0.5 ml of one of the four prebiotics (final prebiotic 
concentration 20 mg/ml) or sterile water as a control and these mixtures were immediately used 
in the infection assay. The inoculum size (about 3 x 108 cells/ml) was determined by plating 
diluted samples on BHI supplemented with erythromycin and nalidixic acid. 
 
2.5. Incubation of L. monocytogenes with carbohydrates 
1 ml of one of the four carbohydrates (final concentration 20 mg/ml) or sterile water as a control 
was mixed with 9 ml of an anaerobic grown Listeria culture (either strain 7291, 4446 or ScottA) 
at OD600 = 0.3. After two hours of further growth the culture was spun down and washed 
thoroughly three times. Pellet was resuspended in 10 ml preheated DMEM/10% FBS and used in 
the infection assay. The inoculum size (about 2 x 108 cells/ml) was determined as above. 
 
2.6. Infection assay 
Prior to the infection assay, Caco-2 cells were washed twice in sterile phosphate-buffered saline 
(PBS). Then, 0.5 ml of the previously prepared bacterial suspension was added to each well and 
the plates were incubated for 1 hour at 37º C in a CO2 incubator. The wells were washed three 
times with PBS to remove nonadhered Listeria before 0.1% Triton X-100 were added for 20 
min. Serial dilutions and plating on BHI supplemented with erythromycin and nalidixic acid 
were used to determine the number of adhered and invaded Listeria. Experiments were 
performed in quadruplicate and repeated four times. 
 
2.7. Confocal microscopy 
Cells seeded on glass coverslips were after incubation with Listeria washed three times in PBS 
and fixed in 4% paraformaldehyde. After 20 min the cells were washed twice, dried and mounted 
on glass slides. Cells were observed under an inverted Confocal Microscope (Olympus IX 81) 
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with the 100 x objective. Representative pictures were taken by a person with no knowledge 
about the origin of the samples (with or without XOS).  
 
2.8. Sample preparation and isolation of RNA for qPCR 
One ml of one of the four carbohydrates (final concentration 20 mg/ml) or sterile water as 
control was mixed with 9 ml of each strain of anaerobically grown Listeria (OD600 = 0.3). After 
two hours of further growth, messenger RNA in the bacterial cultures was stabilized by addition 
of RNAlater RNA Stabilization Reagent (Qiagen, Copenhagen, Denmark). Total RNA was 
subsequently isolated using the RNeasy mini kit (Qiagen, Copenhagen, Denmark) according to 
manufactures instructions. To ensure RNA samples were completely free of genomic DNA, all 
RNA samples were DNAse treated as outlined in the protocol of the TURBO DNA-freeTM kit 
(Ambion, Applied Biosystems, Naerum, Denmark). After DNAse treatment, total RNA yields 
were determined using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Wilmington 
DE 19810, USA) and RNA quality (integrity) was verified by electrophoresis on a 2100 
Bioanalyzer (Agilent Technologies, Naerum, Denmark) using an RNA 6000 Nano Chip (Agilent 
Technologies, Naerum, Denmark).  
 
2.9. Quantitative Real-Time PCR (qPCR) 
The mRNA transcripts of seven genes were quantified using qPCR. Primers were designed using 
Primer Blast (NCBI) (Table 1). Quantitative PCR amplification was performed in a ABI 7900 
Real-Time PCR system (Applied Biosytems, Naerum, Denmark) using the EXPRESS SYBR® 
GreenERTM qPCR Supermix with Premixed ROX kit (Invitrogen A/S, Taastrup, Denmark). 
Aliquots of 200 ng Total RNA of each sample were reverse transcribed into cDNA using the 
SuperScript® VILOTM cDNA synthesis kit and the protocol outlined by the manufacturer 
(Invitrogen A/S, Taastrup, Denmark). Two µL of a 1:100 dilution of the cDNA product was 
added to 18 uL solution containing EXPRESS SYBR® GreenERTM qPCR Supermix with 
Premixed ROX kit (Invitrogen A/S, Taastrup, Denmark) and 200 nM of the forward and reverse 
primers each. 
Amplification was initiated at 95oC for 10 minutes followed by 40 cycles of 95oC for 15 s and 
60oC for 60 s. A melting-curve analysis between 60°C and 95°C was performed after each PCR 
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to check the specificity of the amplification product. This PCR program was found by 
preliminary experiments on target DNA in order to optimize reaction parametres and primer 
concentrations. The program was efficient and consistent for all primers used. During the 
preliminary experiments, the amplification products were further subjected to gel electrophoresis 
in 2% agarose, followed by ethidium bromide staining to verify correct amplicon sizes. All 
samples were measured in either duplicate or triplicate. Control PCR´s were included to detect 
background contamination (no-template control) and to verify that there was no contaminating 
chromosomal DNA (DNAse treated Total RNA sample). In order to compare the expression 
level of each gene across all tested conditions, all expression levels were normalised to the 
expression level of housekeeping gene reference values. The geometric mean of the reference 
values for the Eubacteria 16S gene and the gap gene (lmo2459) of L. monocytogenes were used 
as housekeeping reference gene for these calculations as suggested by Vandesompele et al 
(2002). mRNA quantification was performed in triplicate from RNA extracted from three 
independent cultures. 
 
2.10. Statistical analysis 
Statistical analysis of the adhesions assays were performed using the statistical software in 
Microsoft Office Excel XP (Microsoft, USA). A one-way analysis of variance was used to 
determine the effect of the non digestible carbohydrates on the number of Listeria/Caco-2 cell. 
Tests were considered statistically significant if P values <0.05 were obtained. 
Statistical analysis of quantitative PCR data was performed with SAS JMP version 7.0. After 
graphical verification of the normality assumption, data was analyzed by one-way ANOVA 
followed by a pair-wise multiple comparison of means (Student’s t). Tests were considered 
statistically significant if P values <0.05 were obtained. 
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3. Results 
 
3.1. Effect of mixing with carbohydrates on the adherence of L. monocytogenes to Caco-2 
cells 
The addition of XOS to the bacterial culture immediately before addition of the suspension to the 
Caco-2 cells significantly (P<0.05) reduced the numbers of L. monocytogenes 7291 and ScottA 
adhered or invaded into the Caco-2 cells (Figure 1). Confocal microscopy was used for visual 
inspection of bacteria and Caco-2 cells (Figure 2), and confirmed an apparent lower number of 
adhered bacteria in the presence of XOS. Addition of GOS, inulin or polydextrose had no 
significant effect on the ability of the three strains to adhere to or invade the Caco-2 cells (Figure 
1).  
 
3.3. Effect of incubation with carbohydrates on the adherence of L. monocytogenes to Caco-
2 cells 
Incubation with XOS for two hours, followed by washing of the bacteria, significantly reduced 
the number of adhered and invaded bacteria per Caco-2 cell for all three strains of L. 
monocytogenes (P<0.05 for strain 7291 and 4446, P<0.001 for ScottA). A similar effect was not 
observed for the other carbohydrates (Figure 3).  
 
3.2. Effect of incubation with carbohydrates on expression of L. monocytogenes genes 
potentially involved in adherence 
There was no significant difference in growth OD after two hours incubation between samples 
incubated with different carbohydrates.  
The effect of incubating the cells with the carbohydrates on the expression pattern of seven 
adherence-related genes was comparable for L. monocytogenes strains 4446 and ScottA, while 
the expression profile of strain 7291 was quite different (Figure 4). Several genes were affected 
in 4446 and ScottA, while only one gene (iap) was affected in 7291. Most of the affected genes 
were down-regulated by carbohydrate incubation except for iap, which was up-regulated by 
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inulin and XOS in all three strains, and lap, which was up-regulated by polydextrose in 4446 and 
ScottA (Figure 4).  
 
4. Discussion 
 
We previously reported that four non-digestible carbohydrates had different effects on the 
infective potential of three strains of L. monocytogenes in guinea pigs (Ebersbach et al., 2010).   
In this study, our goal was to investigate the mechanisms accounting for these observations using 
the same strains of L. monocytogenes and the same carbohydrates. We found that XOS 
significantly inhibited the adhesion of two out of three L. monocytogenes strains to Caco-2 tissue 
culture cells when added immediately prior to the start of the infection assay (Figure 1 and 2). 
Additionally, two hours incubation with XOS followed by removal of the carbohydrate reduced 
the adhesion of all three L. monocytogenes strains (Figure 3). This suggests that our previous 
observation that dietary XOS reduces the severity of Listeria infections in vivo (Ebersbach et al., 
2010) may be explained by an inhibition of pathogen attachment to the guinea pig epithelium in 
vivo. However, while our earlier study reported that GOS prevented Listerial infection in guinea-
pigs (Ebersbach et al., 2010), no effect of this carbohydrate on in vitro adhesion to Caco-2 cells 
was observed (Figure 1 and 3). Therefore, different mechanisms may be responsible for the 
preventive effects observed in vivo for these two types of oligosaccharides. Inulin, which 
increased the severity of the infection in guinea pigs (Ebersbach et al., 2010), had no effect on 
Listerial adhesion to epithelial cells lines in the present study (Figure 1 and 3). Polydextrose had 
neither effect in vivo nor in vitro.   
Our observations with XOS (Figure 1 and 3) is consistent with previous reports showing that 
specific oligosaccharides are able to inhibit adherence of gram-negative bacteria to intestinal 
tissue culture cells (Lee and Puong, 2002;Shoaf et al., 2006;Rhoades et al., 2008;Searle et al., 
2009).  According to the anti-adherence model, these oligosaccharides act as receptor decoys for 
pathogens by mimicking the host cell receptor on the intestinal cell, to which the pathogen 
adheres before internalization. By binding to the oligosaccharide instead of to the intestinal cells, 
the pathogen is washed from the gastrointestinal tract and does not cross the epithelial barrier.  
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Strain 4446 is the only one of the three L. monocytogenes strains, that ferments XOS (Ebersbach 
et al., 2010), and  additionally the only one for which adhesion is not blocked by mixing with 
XOS (Figure 1). We speculate that because strain 4446 metabolizes XOS, it is taken up by the 
bacteria instead of sticking to the cell surface and blocking adherence to the Caco-2 cells. 
However, it should be noted that inhibition of adherence of strain 4446 was seen after incubation 
with XOS (Figure 3), suggesting that this oligosaccharide blocks Listerial adhesion through other 
mechanisms than direct interaction with the bacterial surface.  
It is well known that carbohydrates influence expression of virulence genes in L. monocytogenes, 
either because the carbohydrate functions as a signaling molecule per se or more likely as a 
result of catabolite repression (Milenbachs et al., 1997;Gilbreth et al., 2004). This led us to 
investigate if incubation with different carbohydrates affected expression of genes known to be 
involved in the infection and internalization pathways in L. monocytogenes. 
The effect on adherence gene expression of strain 7291 was markedly different from the effects 
on strain 4446 and ScottA, which were almost identical (Figure 4). Most of the seven genes of 
strain 4446 and ScottA were affected by incubation with the carbohydrates, while the only gene 
affected in strain 7291 was iap (Figure 4A). However, this different expression profile of strain 
7291 was not reflected in the in vitro adherence assay (Figure 3). While only XOS reduced the 
adherence of L. monocytogenes to the Caco-2 cells lines, all of the four prebiotics significantly 
down regulated the expression of inlA in strain 4446 and ScottA. Still, it was XOS that had the 
strongest effect on the expression of inlA, which encodes the surface protein Internalin A. 
Through its interaction with the host cell receptor E-cadherin (Mengaud et al., 1996), Internalin 
A is believed to be the primarily protein involved in infection of enterocytes by L. 
monocytogenes (Lecuit et al., 2001). We speculate that the expression of inlA would need to 
drop below a certain level before affecting the measured in vitro adherence. Indeed, expression 
of inlA is known to differ between strains of L. monocytogenes, and a correlation exists between 
the level of inlA expression and the invasion capacity into Caco-2 cells (Werbrouck et al., 2006).  
The expression of actA and inlA are positively regulated by PrfA the master virulence regulator 
of L. monocytogenes (Milohanic et al., 2003), and σB, which positively regulates the expression 
of iap (Hain et al., 2008). On the contrary, not much is known about the regulation of expression 
of the other four tested genes. Since many of the genes of strains 4446 and ScottA are similarly 
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down- or up-regulated after incubation with indigestible carbohydrates (Figure 4), it may be 
speculated that the expression of some of the genes is controlled by a common gene regulator.  
Several autolysins have been shown to play a role in the adherence of L. monocytogenes to 
intestinal cells and their role might be to fine tune the surface architecture of L. monocytogenes 
priming the bacteria for adherence and invasion of enterocytes. The autolysins believed to be 
involved in adherence of L. monocytogenes are Ami, p60 and Auto, encoded by ami, iap, and 
aut, respectively (Milohanic et al., 2001;Cabanes et al., 2004;Faith et al., 2007). While ami and 
aut were downregulated by one or more of the tested carbohydrates in 4446 and ScottA, iap was 
significantly up-regulated by inulin and XOS in all three Listeria strains (Figure 4). However, 
these effects were not reflected in the phenotypic adhesion to Caco- 2 cells (Figure 3).    
Another protein that has been shown to be important for adherence of L. monocytogenes is the 
protein LAP (Listeria adhesion protein). LAP is involved in binding of L. monocytogenes to 
several human intestinal cell lines via interaction with its receptor Hsp60 (Heat shock protein 
60). L. monocytogenes also has the ability to bind to cell-surface fibronectin through FbpA 
(fibronectin-binding protein A) which has been shown to be important for oral infection of 
transgenic mouse (Dramsi et al., 2004). Expression of LAP was seen to be significantly down-
regulated by incubation with XOS, but up-regulated by incububation with polydextrose in strains 
4446 and Scott A, which may contribute to the observed inhibitory effect of XOS on in vitro 
adherence (Figure 3) as well as on in vivo infection (Ebersbach et al., 2010).  
The surface protein ActA is a major virulence factor of L. monocytogenes, mediating actin-based 
intra- and intercellular spread (Smith et al., 1995). In addition, the ability of L. monocytogenes to 
adhere to intestinal cell lines is significantly impaired if ActA is deleted (Suarez et al., 2001). 
Furthermore, expression of ActA enables L. innocua to invade epithelial cells, suggesting that 
ActA might also play a role in the intestinal adherence of L. monocytogenes (Suarez et al., 
2001). Expression of ActA was significantly reduced in strain 4446 by three out of four 
carbohydrates, and in strain ScottA by all of the tested carbohydrates.  
Collectively, our results suggest that dietary carbohydrates may alter the adhesive and infective 
potential of L. monocytogenes present in the intestine through direct sticking to the bacterial 
surface, as well as through effects on expression of adhesion-related genes. In particular, XOS 
had a significant reductive effect on the adhesion of L. monocytogenes to epithelial cells in vitro, 
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which may explain the previously reported preventive effect of this oligosaccharide on in vivo 
infection (Ebersbach et al., 2010).     
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Target Name Sequence (5'→3') Amplicon  Source 
ActA ActA_1F GCTTCGGACTTCCCGCCACC 172 bp This study 
 ActA_1R GCATTGGCGTCTCTGGCAAAGC  This study 
InlA InlA-F CGGATAAAATGCCGACAAAT 147 bp This study 
 InlA-R CTTTTGTTGGTGCCGTAGGT  This study 
LAP LAP-F TCCTCACGGTCGTGCCAATGC 157 bp This study 
 LAP-R AGTTGCAGCAGGGAAGCCGA  This study 
Ami Ami-F AATGTCCGCAGCGGTCCTGG 141 bp This study 
 Ami-R CCAGCTTGCAACCCAACCGC  This study 
FbpA FbpA-F CCATCAACCGTTCTCGCATGAACTT 142 bp This study 
 FbpA-R CATCGGTGGGGTTGCTGGGT  This study 
p60 p60-F GCGCTACTGGCCCAAGCTGT 109 bp This study 
 p60-R GCAGAGGCATATTGTTGCTTCGC  This study 
Aut Aut-F ACGGTTTGACAACTGTTGGCGG 133 bp This study 
 Aut-R GCCTGGGCAGCAGGTGCTATTT  This study 
 
Table 1: Primers used for qPCR in this study. 
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Figure 1: Inhibition of L. monocytogenes adhesion to Caco-2 tissue culture cells by 
carbohydrates. Values significantly different from the control group (no carbohydrates) are 
marked by stars. *: P < 0.05. 
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Figure 2: Confocal microscopy showing representative fields of Caco-2 cells challenged with L. 
monocytogenes strains 7291 (AC) and ScottA (BD) before (AB) and after (CD) mixing of the 
Listerial cells with XOS.  
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Figure 3: Inhibition of L. monocytogenes adhesion to Caco-2 tissue culture cells after incubation 
of the bacteria for two hours with the respective carbohydrates, followed by thorough washing. 
Values significantly different from the control group (no carbohydrate) are marked by stars. *: P 
< 0.05; *** <0.001. 
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Figure 4: mRNA levels of L. monocytogenes strains 7291 (A), 4446 (B), and ScottA (C). Results 
were calculated relatively as ratios to control group (no carbohydrate), which was set to 100. 
Values significantly different from the control group are marked by stars. *: P < 0.05; **: P < 
0.005; ***: P <0.001. 
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